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ABSTRACT	  
 
Healthy ageing and Parkinson’s disease are both characterized by different changes in the prefrontal 
cortex and in dopaminergic functionality. Working memory and feedback processing have been 
related to the dopaminergic activity in the prefrontal cortex (Hämmerer & Eppinger, 2012; Bäckman 
et al., 2010-2008; Bäckman & Farde, 2005). The aim of the three studies presented in this thesis was 
to examine if, and how, these two executive functions change in ageing and in Parkinson’s disease 
patients under pharmacological treatment. In detail, a first study investigated executive attention and 
inhibitory control, top down components of working memory, with the aim to explore the 
management of the information stored in working memory. Feedback processing was instead 
investigated in the second study exploring the interaction between motivation and cognitive control 
and, in the third study, analysing the electrophysiological correlates of outcome evaluation in a 
decision-making task.  
Results of the first study highlighted the presence of an age-related decline in top down components 
of working memory, like executive attention and inhibitory control, in line with findings about age-
related vulnerability to interference and decline in WM (Reuter-Lorenz & Sylvester, 2005). In 
addition, the results of this study showed as medicated PD patients performed like a matched control 
group of healthy elderly in terms of accuracy, but better in terms of latency.  
Results of the second study indicated that feedback processing is preserved in healthy ageing, but 
impaired in medicated PD patients, in line with previous findings (Kapogiannis et al., 2011; Spaniol 
et al., 2011; Harsay et al., 2010; Kobayakawa et al., 2010; Bodi et al., 2009; Frank et al., 2007-2004). 
Results of the third study contributed to increase the knowledge of this impairment showing the 
presence of abnormal electrophysiological correlates of feedback processing in medicated PD 
patients. 
Taken together, the results presented in this dissertation confirm the presence of specific age-related 
declines in executive functions (Verhaeghen, 2011), and also suggest that the pattern of 
performances of medicated PD patients could be compatible with the effect of a dopaminergic 
“overdose” in executive functions (Vaillancourt et al., 2013), recommending further investigations 
about the role of dopaminergic treatment in PD patients’ cognition. 
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RIASSUNTO	  
 
L’invecchiamento sano e la malattia di Parkinson rappresentano due condizioni in cui la corteccia 
prefrontale e il sistema dopaminergico vanno incontro a diversi cambiamenti. La memoria di lavoro e 
l’elaborazione del feedback rappresentano due funzioni esecutive che sono state correlate all’attività 
dopaminergica nella corteccia prefrontale (Hämmerer & Eppinger, 2012; Bäckman et al., 2010-2008; 
Bäckman & Farde, 2005). L’obiettivo dei tre studi presentati in questa tesi è stato quello di studiare 
se, e come, queste due funzioni esecutive vanno incontro a cambiamenti, durante l’invecchiamento 
sano e in pazienti con malattia di Parkinson. Nello specifico, nel primo studio sono state esplorate le 
componenti top-down della memoria di lavoro, ovvero la capacità di focalizzare le risorse 
sull’informazione rilevante e di inibire l’elaborazione di quella irrilevante, capacità essenziali per la 
gestione di informazioni in memoria di lavoro. L’elaborazione del feedback è stata invece studiata 
indagando i meccanismi d’interazione tra controllo cognitivo e motivazione nel secondo studio, e 
analizzando i correlate elettrofisiologici (ERPs) dell’elaborazione del feedback in un compito di 
decision-making nel terzo studio.  I risultati del primo studio hanno mostrato che 
nell’invecchiamento sano le componenti top-down della memoria di lavoro vanno incontro ad un 
declino, coerentemente con precedenti evidenze circa l’aumentata sensibilità all’interferenza e la 
presenza di deficit di memoria di lavoro nell’invecchiamento (Reuter-Lorenz & Sylvester, 2005). 
Pazienti con malattia di Parkinson sotto trattamento farmacologico hanno invece mostrato prestazioni 
comparabili a quelle del gruppo di controllo in termini di accuratezza, ma migliori in termini di tempi 
di risposta. I risultati del secondo studio hanno inoltre mostrato che mentre nell’invecchiamento sano 
la capacità di elaborazione del feedback è preservata, questa stessa capacità è compromessa in 
pazienti con malattia di Parkinson sotto trattamento farmacologico, coerentemente con quanto 
riportato in letteratura (Kapogiannis et al., 2011; Kobayakawa et al., 2010; Harsay et al., 2010; 
Spaniol et al., 2011; Bodi et al., 2009; Frank et al., 2007-2004). I risultati del terzo studio hanno 
contribuito a questa letteratura mostrando la presenza di anomalie nei correlati elettrifisiologici 
dell’elaborazione del feedback, in pazienti con malattia di Parkinson sotto trattamento 
farmacologico. In conclusione, i risultati presentati in questa tesi confermano la presenza di specifici 
deficit a livello delle funzioni esecutive nell’invecchiamento sano (Verhaeghen, 2011) e 
suggeriscono una compatibilità con l’ipotesi di una “overdose dopaminergica” alla base dei deficit 
esecutivi dei pazienti con malattia di Parkinson sotto trattamento farmacologico, ipotesi su cui 
dovranno concentrarsi futuri approfondimenti.  
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CHAPTER	  I	  
EXECUTIVE	  FUNCTIONS	  
	  
“Human cognition is forward-looking, proactive rather than reactive. It is driven by 
hopes, plans, goals, ambitions, and dreams, all of which pertain to the future and not to 
the past.  These cognitive powers depend on the frontal lobes and evolve with them. The 
frontal lobes endow the organism with the ability to create neural models as a 
prerequisite for making things happen, model of something that, as of yet, does not exist 
but which you want to bring into existence”. 
(Goldberg & Bougakov, 2007) 
 
1.1	  Definition	  of	  executive	  functions	  
 
Despite the frequency with which it is mentioned in the neuropsychological literature, 
the concept of executive functions (EF) is linked to several problems, concerning 
definition, conceptualization and measurement. The reason of that is not the newness of 
this concept, because the notion of EF arose in the 1840s when scientists tried to 
understand the functions of the prefrontal cortex (PFC) (Luria, 1966; Harlow, 1868-
1848). For this reason EF initially were generally defined as what the prefrontal lobes 
do (Pribram, 1976-1973), but of course this definition is insufficient. Research efforts, 
aimed to explore the different aspects of this complex concept, have often yielded 
contradictory findings, resulting in a lack of clarity and in the presence of controversies 
regarding the true nature of EF (Jurado & Rosselli, 2007). A clear definition of EF 
would be necessary to determine which human mental functions can be considered 
executive in nature and which one cannot be so classified (Barkeley, 2012). 
Unfortunately, the concept of EF is actually expressed by different definitions (table 1), 
and there is neither a consensus definition nor an explicit operational definition of EF. 
Trying to summarize most points of view, it is possible to affirm that problem-solving, 
working memory, planning, sustained attention, inhibitory control, feedback processing, 
multitasking and cognitive flexibility are considered the “cool” components of EF.  
At the same time, in EF construct are also included “hot” components, which are 
cognitive processes that involve more emotional arousal and are represented by the 
capacity to deal with novelty, decision-making, social and emotional behaviour 
regulation (Zelazo & Cunningham, 2007).  
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Currently, it is possible to consider EF as un “umbrella term” in which both cold and 
hot components are considered as high-level cognitive functions, which are involved in 
the control and in the regulation of lower-level cognitive and behavioural processes 
(Chan et al., 2008; Alvarez & Emory, 2006). Unfortunately, the lack of single agreed 
upon definition of EF is linked to other important open questions concerning EF: How 
do EF work? How are EF to be assessed? (Barkley, 2012). The aim of this chapter is to 
propose an overview of these critical issues about EF. To explain how EF work, 
principal cognitive and neuroanatomical models will be reviewed; moreover, a 
description of the principal methods for EF assessment will be provided. 
	  
TABLE	  1.1	  Sampling	  of	  definition	  of	  EF	  (adapted	  from	  Barkley,	  2012).	  
AUTHOR/S	   DEFINITION	  	  
Luria,	  1976	   …	  Executive	  processes	  are	  essential	  for	  the	  synthesis	  of	  external	  stimuli,	  
formation	   of	   goals	   and	   strategies,	   preparation	   for	   action,	   and	  
verification	   that	   plans	   and	   actions	   have	   been	   implemented	  
appropriately.	  
	  
Norman	  &	  
Shallice,	  1986	  
The	  umbrella	  concept	  of	  “executive	  control”	  encompasses	  those	  cognitive	  
functions	   involved	   in	   the	   selection,	   scheduling	   and	   coordination	   of	   the	  
computational	  processes	  responsible	  for	  perception,	  memory	  and	  action.	  
	  
Stuss	  &	  
Benson,	  1986	  
Executive	   functions	   is	  a	  generic	   term	  that	   refers	   to	  a	  variety	  of	  different	  
capacities	   that	   enable	   purposeful,	   goal-­‐directed	   behaviour,	   including	  
behavioural	   regulation,	   working	   memory,	   planning	   and	   organizational	  
skills,	  and	  self-­‐monitoring.	  	  
	  
Baddeley,	  1986	   The	   term	   executive	   functioning	   generally	   refers	   to	   the	   mechanisms	   by	  
which	  performance	  is	  optimized	  in	  situations	  requiring	  the	  operation	  of	  a	  
number	  of	  cognitive	  processes.	  
	  
Lezak,	  1995	   The	  executive	  functions	  consist	  of	  those	  capacities	  that	  enable	  a	  person	  to	  
engage	  successfully	  in	  independent,	  purposive	  self-­‐serving	  behaviour.	  
	  
Burgess,	  1997	   [Executive	   functions	   are]	   a	   range	  of	   poorly	   defined	  processes	  which	   are	  
putatively	   involved	   in	   activities	   such	   as	   “problem	   solving”…	   “planning”…	  
“initiation”	  of	  activity,	  “cognitive	  estimation”	  and	  “prospective	  memory”.	  
	  
Anderson,	  2002	   Executive	  functions	  are	  responsible	  for	  coordinating	  the	  activities	  involved	  
in	  goal	  completion	  such	  as	  anticipation,	  goal	  selection,	  planning,	  initiation	  
of	   activity,	   self-­‐regulation,	   deployment	   of	   attention	   and	   utilization	   of	  
feedback.	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1.2	  Theories	  and	  models	  of	  executive	  functions	  
 
Alexander Luria was one of the first scientists who wrote extensively about EF. His EF 
theory was developed documenting the behaviour of patients with frontal lobe damage. 
For this reason, Luria’s functional analysis referred to what EF are and do in terms of 
cognitive and behavioral outcomes of a frontal damage. Luria (1976-1966) postulated 
the existence of three functional brain units. The first is a subcortical unit, mainly 
located in the brain stem, and it is responsible of arousal and consciousness. The second 
unit, which refers to the temporal, parietal and occipital lobes, is responsible for 
encoding, processing and storage of sensory information. Finally, the third functional 
unit consists of the frontal lobes, which is responsible of programming, regulation and 
verification of goal-directed behaviour. With this model Luria (1976-1966) proposed 
that the prefrontal cortex (PFC), included in the third unit, is superimposed on all other 
cortical areas, and performs a role of supervision and regulation of mental activity and 
behaviour. According to this model, damage to the frontal lobe, and in particular the 
PFC, is expected to, causing several cognitive and behavioural disorders linked to an 
inefficient regulation of behavioural outcomes.  
After Luria, different theories and models accounted EF using the concept of a central 
control system. These models, which agree about complexity and importance of EF to 
human adaptive behaviour, proposed different conceptualizations regarding what mental 
processes actually constitute EF, the presence of possible subcomponents, and which 
are the variables that measure them. In the effort to develop a coherent EF model, two 
main branches of theories were followed: models in which one single underlying ability 
explains all the components of EF, developed by unitary theories of EF, and models in 
which EF constitute related but distinct processes, inspired by multiple processes 
theories of EF (Jurado & Rosselli, 2007).  
The two main representative models inspired to unitary theories are the Norman and 
Shallice (1986) and the Baddeley and Hitch’s (1974) models (see also Baddeley, 2000- 
1986). The first (Norman & Shallice, 1986) is based on the existence of two principal 
systems, responsible of programming, regulating and verifying of human actions (figure 
1.1). The first system, called Contention Scheduling, has the control of routine and 
overlearned actions and provides the selection of appropriate responses basing on 
contextual information. The second system, on the other hand, occurs in non-routine 
situations, where automatic responses could be not available or appropriate.  
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SUPERVISORY	  ATTENTIONAL	  SYSTEM	  
RESPONSE	  PATTERNS	  
CONTENTION	  SCHEDULING	  
This second system is called Supervisory Attentional System (SAS) and represents the 
higher control mechanism necessary for the correct behavioural regulation.  
Similarly to Norman and Shallice’s model (1986), also in the Baddeley and Hitch’s 
(1974) model was hypothesized the presence of a higher control mechanism, even if the 
authors’ goal was to clarify the role of working memory within EF. In fact, together 
with a Central Executive (CE), responsible for the control and regulation of cognitive 
processes, Baddeley and Hitch’s model (1974) involves three subsidiary systems: a 
visuo-spatial sketchpad for the manipulation of visual information; a phonological loop, 
for the manipulation of speech-based information; finally an episodic buffer, which 
links information across domains to form integrated episodic representations of visual, 
spatial, and verbal information.  Comparing the two models, both SAS (Norman & 
Shallice, 1986) and CE (Baddeley, 2000; Baddeley and Hitch; 1974) models represent 
central and supervisory systems that preside over cognitive processes.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 1.1: schematic representation of the Norman and Shallice SAS model (1986). 
Two principal mechanisms are present: the contention scheduling provides the selection of 
appropriate responses basing on contextual information; the Supervisory Attentional 
System intervenes when automatic responses could be not available or appropriate. 
 
 
In addition to the two main theories explained above, other unitary theories of EF could 
be found in the literature. The Duncan’s goal neglect theory (Duncan, 1986; see also 
Duncan et al., 2000; Duncan & Owen, 2000; Duncan, 1995) can be considered another 
unitary theory of EF.  
response	  stimulus	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Analysing clinical evidences, Duncan and colleagues suggested that the principal deficit 
of patients with frontal lobe damage concerned the loss of control of action and its 
desired results. On the basis of these evidences, Duncan proposed a model of EF 
emphasizing the role of goals in the behavioural regulation: goals impose a structure on 
the behaviour, by controlling the activation or the inhibition of actions.  
Duncan proposed that the common mechanism that underlies EF is the behavioural 
organization depending on the goals achievement. Following this model, behaviour 
would be under the control of particular set of goals, which elicit the relevant actions 
from a large potential store of behaviours. These goals are formulated, stored and 
checked by a subjective order, to behave optimally and properly in response to 
environmental or internal demands (Chan et al., 2008). The goal achievement is related 
to the function of the frontal cortex and in patients with frontal lobe damage, the typical 
structure of goal directed behaviour is disrupted. Patients with frontal lobe damage are 
able to remember the intended goals, however they show a disorganized behaviour, 
failing to achieve the intended goals. Duncan (1986) referred to the executive 
dysfunction of these patients with the expression “goal-neglect”. 
In contrast to the described unitary views, different EF theories were proposed, 
excluding the existence of an underling unique system and stressing a multiple nature of 
EF. These multiple processes theories permitted the elaboration of different EF models, 
developed with the aim to add details and levels to the unitary models.  
An example of multiple processes model is the Fuster’s (1997) cross-temporal synthesis 
model.  
As Duncan, Fuster (1997) focused on the goal achievement capacity, defined as cross-
temporal synthesis. Fuster’s model excluded the concept of a central executive control 
system and represented EF as the integration of multiple components. Fuster sustained 
that goal directed behaviour is realized by the representation of events, responses and 
goals. These three representations arise from three specific EF components: working 
memory, planning and interference control. According to Fuster (1997), these three EF 
components are fundamental for the “cross-temporal organization of behaviour”. 
Deficits in any of the three components can result in a deficient temporal integration of 
behaviour, and give rise to distinct disorders of EF.  
Few years later, Stuss and Alexander (2000) elaborated a different multiple processes 
model.  
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Offering a different interpretation of the SAS model (Norman & Shallice, 1986), Stuss 
and Alexander (2000) proposed the existence of three levels of behavioural monitoring, 
which developed progressively in humans. The first level comprises the automatic 
execution of overlearned routine activities. This level is suggested to reflect the function 
of subcortical systems (Slattery et al. 2001). The second level includes the information-
processing act to organize a goal-directed behaviour; this level reflects the function of a 
controlled mechanism with supervisory function. The third and highest level is 
represented by the awareness, of both oneself and the environment. Adding this third 
level, Stuss and Alexander (2000) integrated the SAS model (Norman & Shallice, 1986) 
with an higher level of control, going beyond the distinction between controlled and 
automatic processes, indicted to be insufficient for explaining EF. 
A final example of a multiple processes theory is provided in figure 1.2, which 
describes the model of Brower and Schmidt (2003).  
 
   
 
FIGURE 1.2: schematic representation of the Brower and Schmidt model of EF (2003). 
Above the horizontal dotted line are represented EF: self-monitoring and control 
mechanisms. Below the line automatic aspects of information processing are represented. 
Motivational aspects influence both controlled than automatic aspect of the information 
processing. 
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Even this model could be considered as a supplement to the Norman and Shallice’s 
model (1986). Brower and Schmidt (2003), in fact, confirmed the presence of both 
controlled and automatic processes, adding however more details. Authors translated 
the concept of contention scheduling talking about the automatic information processing 
and hypothesized the existence of a more complex control mechanism. In the model of 
Brower and Schmidt (2003), planning and working memory abilities are required in 
condition of discrepancy between actual and required goal attainment. These two 
abilities work together as a control mechanism that intervenes when automatic 
processing is not sufficient. Respect to the SAS model (Norman & Shallice, 1986), 
Brower and Schmidt (2003) introduced the concepts of motivation and awareness to 
explain the collaboration between controlled and automatic information processing. In 
detail, automatic information processing interacts with a motivational representation of 
goals. This motivational representation would influence also the controlled processing, 
interacting with a self-monitoring process, critical for the activation of the controlled 
mechanism, and then for the appropriate behavioural management (Brower & Schmidt, 
2003). 
In summary, both unitary and multiple processes models can be classified as 
hierarchical models that, interpreting EF as the higher level of cognition, respectively 
identifying one or more mechanisms to represent this level, necessary for the 
appropriate cognitive and behavioural regulation.  
The clinical observation of double dissociations, together with the increasing results of 
functional neuroimaging studies, sustain a multi-component view of EF, in which may 
coexist the presence of clearly distinguishable domains that, at the same time, share 
some underlying commonality (Salthouse, 2005-1996; Fisk & Sharp, 2004; Miyake et 
al., 2000). This multi-component view is also the emerging idea in the debate about the 
neural basis of EF: as will be explained in the next paragraph, what is emerging from 
functional and clinical evidences is the idea that different EF are not mediated 
exclusively by the frontal areas, but depend on different brain regions as well (Boelen, 
2011). 
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1.3	  Neural	  basis	  of	  executive	  functions	  
 
The earlier studies on neural basis of EF are linked to the observation of patients with 
frontal lobe damage, who often showed cognitive and behavioural abnormalities 
attributable to an EF deficit. In a first attempt to find a specific correspondence between 
neural substrate and cognitive functions, different components of EF were associated 
with three principal regions of the PFC (Sbordone, 2000; Cummings, 1995; Stuss & 
Benson, 1984). The dorsolateral PFC was related to planning, problem solving, working 
memory and mental flexibility, while the ventromedial and the orbital sections of the 
PFC were associated inhibition capacity, drive and initiative, and the regulation of 
social behaviour (Grossi & Trojano, 2005). Despite the fact that this distinction is based 
on clinical and functional evidences and still represents the principal functional 
framework of EF, it is obviously a schematic model of anatomical-functional 
correspondence. 
Given the complexity of the argument, even in this case there is no clear agreement 
about neural basis of EF: as consequence of different evidences, there remains an on-
going debate regarding how EF are regulated by the frontal cortex (Alvarez & Emory, 
2006; Welsh, 2002; Miyake et al., 2000). As defined by Stuss and Knight (2013) the 
frontal cortex is “… one of the latest structure of the brain to evolve, uniquely endowed 
with the capacity to pre-adapt the human being to her environment, and connected 
practically to every other structure of the brain”. This assumption highlights the 
importance to consider the connections between frontal cortex and other brain structures, 
in the study of neural basis of EF. In fact, together with evidences of specific 
associations between EF and different regions of the frontal lobes (Stuss et al. 2002; 
Koechlin et al. 2000; Stuss & Alexander 2000), is now accepted that EF are as well 
distributed over a wide cerebral network, which includes subcortical structures and 
thalamic pathways (Jurado & Rosselli, 2007; see also Monchi et al. 2006; Kassubek et 
al. 2005; Lewis et al. 2004).  
This shared idea of a dynamic and flexible network that supports EF (Elliott, 2003) is 
sustained by several imaging and lesion studies. In a meta-analytic review, Alvarez and 
Emory (2006) provided a critical analysis of lesion and neuroimaging studies using EF 
measures. In detail, authors examined the validity of EF construct in terms of its relation 
to activity and damages to the frontal lobes. Alvarez and Emory (2006) found 
inconsistent results that did not support a one-to-one relationship between EF and 
frontal lobe activity: many functional neuroimaging studies, which explored neural 
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basis of EF using validated measures, demonstrated that the performance at these tests 
is often related to a distributed neural activation, of frontal and non-frontal brain regions. 
For example, particular attention has received the exploration of subcortical and 
thalamic pathways that originates in the PFC (Royall et al. 2002; Baddeley, 1998). In 
detail, connections between PFC and subcortical structures as the caudate, striatum and 
the nucleus accumbens, are now considered as crucial for the EF. The mentioned 
distinction between the functional roles of dorsolateral, ventromedial and orbitofrontal 
cortex is in fact currently translated in the study of the dorsolateral, ventromedial and 
orbitofrontal pathways functions (see figure 1.3). 
Exploring the involvement of these pathways instead of PFC regions, several evidence 
promoted a more complete view of EF neural bases.  
 
 
 
 
FIGURE 1.3: schematic view of fronto-striatal pathways with main functional outcomes of 
their dysfunctions. LOC: lateral orbitofrontal cortex; MOC: medial orbitofrontal cortex 
(from Vale, 2008).   
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Mental flexibility, set shifting and planning, together with working memory, reasoning, 
problem-solving and abstract thinking, are now related to the projections of the 
dorsolateral PFC to the dorsolateral head of the caudate nucleus (Malloy & Richardson, 
2001; Duke & Kaszniak, 2000; Grafman & Litvan, 1999; Cummings, 1993; Jonides et 
al., 1993; Ettlinger et al., 1975; Milner, 1971). Inhibition capacity and emotional 
regulation are now considered as linked to the orbitofrontal pathway, which involves the 
dorsolateral caudate nucleus and the nucleus accumbens (Cummings, 1995; Blumer & 
Benson, 1975). Finally, motivation, initiative and the regulation of social behaviour are 
now related to the ventromedial circuit, which involves the anterior cingulate cortex, 
connected to the ventromedial caudate nucleus (Sbordone, 2000). 
Taken together, even if these evidences demonstrated that PFC has a main role in EF, 
they also highlight that different brain regions are involved in EF. Being the higher-
level of cognitive processing, it is likely that EF requires participation and coordination 
of activities among different brain areas. Therefore, it is possible to consider EF as a 
“macro-construct”, in which different high order abilities refer to the functioning of 
PFC and brain regions to it connected. 
 
 
1.4	  Evaluation	  of	  executive	  functions	  
 
After defining EF on behavioural and anatomical levels, the question arises how 
these functions could be assessed. The on-going controversy regarding the formal 
definition of EF makes the assessment of these functions a delicate matter. In absence of 
an operational definition of EF, the question is about what method is qualified as a 
measure of EF and what is not. Neuropsychology answered this question using 
psychometric tests, built on the basis of their sensitivity to prefrontal damages. Several 
instruments, described as “frontal’’ tests, were developed to measure EF and are widely 
used in research and clinical practice (see table 1.2). However, there is an on-going 
debate on approaches to measuring EF and no gold standard for the EF assessment has 
been agreed upon. Despite the clinical utility of the most common EF tests, three main 
methodological problems motivate this debate.  
Firstly, most of the conventional EF tests may be limited by their own test-retest 
reliability.  
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Theoretically, only novel task can assess EF: for this reason, the test-retest 
reliability of an EF test is usually relatively low (Rabbitt, 1997). Secondly, a lack of 
ecological validity characterizes some of these tests: different findings reported a low 
correlation between the performance at these tests and the real life activity functioning of 
frontal patients (for reviews see Barkeley, 2012; Jurado & Rosselli, 2007). Finally, there 
is the problem of “task impurity” (Burgess, 1997), caused by the nature of EF construct. 
In fact, the execution of a task, believed to measure EF, can in reality trigger non-
executive lower level processes, which are unrelated but necessaries to the execution of 
the task (Hughes & Graham 2002). Taken together, all these methodological problems 
arise from the lack of a shared operational definition. Validity and task specificity of a 
test are in fact difficult to determine when the construct to measure is ill defined. 
In conclusion, the evaluation EF is a thorny matter. Until new methods will be 
developed, the study of EF can rely on tests that have been historically purported as 
measuring the functions of the frontal lobe (Jurado & Rosselli, 2007). However, all the 
methodological limits of these tests justify the development of new tasks and new 
procedures for the study of EF, of which an attempt will be presented in this thesis. 
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TABLE	  1.2	  Common	  EF	  tests	  used	  in	  clinical	  and	  research	  practice.	  
 
Test	  	   EF	  components	  evaluated	  	  
Stroop	  test	  	  
(Stroop,	  1935;	  Golden,	  1978)	  
Inhibitory	  control	  	  
Trial	  Making	  Test	  
(AITB,	  1944;	  Reitan,	  1955-­‐
1992)	  
Set-­‐	  switching;	  Inhibitory	  control	  
Simon	  task	  	  
(Simon,	  1969)	  
Cognitive	  control	  	  
Tower	  of	  London	  	  
(Shallice,	  1982)	  
Planning	  	  
Wisconsin	  card	  sorting	  test	  	  
(WCST;	  Heiton	  et	  al.,	  1993;	  
modified	  version	  Nelson,	  1976)	  
Set	  shifting;	  Set	  maintenance;	  Inhibitory	  control;	  Rule	  
detection	  
Phonemic	  fluency	  Test	  	  
(Benton	  and	  Hamsher;	  1989)	  
Verbal	  production;	  Response	  generation;	  Inhibitory	  
control	  
Semantic	  fluency	  Test	  
(Goodglass	  &	  Kaplan,	  1972)	  
Verbal	  production;	  Mental	  flexibility;	  Inhibitory	  control	  
Iowa	  Gambling	  task	  
(Bechara	  et	  a.,	  1994)	  
Feedback	  based	  learning;	  Decision	  making	  
Sustained	  attention	  	  
to	  response	  task	  
(SART;	  Robertson	  et	  al.,	  1997)	  
Sustained	  attention;	  Inhibitory	  control	  
N-­‐Back	  task	  
(Callicot	  et	  al.,	  1998)	  
Working	  memory;	  Monitoring	  
Frontal	  Assessment	  Battery	  	  
(FAB;	  Dubois	  et	  al.,	  2000)	  
Abstract	   thinking;	  mental	   flexibility;	   Inhibitory	   control;	  
Environmental	  independence	  
Behavioural	  Assessment	  of	  	  
Dysexecutive	  Syndrome	  
(BADS;	  Wilson	  et	  al.,	  1996)	  	  
Planning;	  Organising;	  Initiating;	  Monitoring;	  	  
Problem	  solving;	  Adapting	  behaviour	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CHAPTER	  II	  
AGEING	  AND	  EXECUTIVE	  FUNCTIONS	  
 
2.1	  Executive	  functions	  in	  cognitive	  psychology	  of	  ageing	  	  
 
The understanding of age-related changes in cognitive processes, i.e. the object of the 
cognitive psychology of ageing (CPA), is increased over the last 50 years. Precisely, 
what is increased concerns both theories and methods for the study of cognitive ageing. 
Understanding of age-related changes in cognition is challenging and uneasy for several 
reasons. Firstly because behavioural research on ageing has mapped contrasting patterns 
of both decline and stability in cognition across the adult lifespan (Hedden & Gabrieli, 
2004); secondly because cognitive effects of old age vary in frequency, direction, and 
extent (Band et al. 2002). As pretty much in every scientific field, what research does is 
to try to increase the knowledge, building, improving and integrating theories and 
methods. The proof of this growing process is the presence of many, older and newer, 
models and theories about cognitive ageing, that were developed with the principal aim 
to identify explanations that are coherent with the empiric results.  
Several CPA models and theories have been developed. First models have tried to 
define the age-related changes as qualitative or quantitative, or categorized these 
changes as impairments in low or high levels of cognitive processing (Band et al., 
2002); more recent approaches focus on a different kind of distinction. The prevalent 
dichotomy in modern CPA theories is between specific or general impairments. The 
current debate is in fact between theories that account for the existence of specific age-
related cognitive impairments and theories that attribute the effect of ageing on 
cognition to limited and more general cognitive mechanisms (for a review see Hertzog, 
2008). The general models that are supported by meta-analyses of data across different 
task domains, try to identify a single factor that may explain the variability, while the 
specific models focus on a more circumscribed and domain specific view of cognitive 
ageing, demonstrating task-specific inconsistent changes.  
The most representative general models on cognitive ageing are: the processing 
resource theory (Hultsch, 1998; Salthouse, 1991), the self-initiated processing theory 
(Craik & Byrd, 1982) and the inhibitory loss theory (Hasher & Zacks, 1988).  
	  22	  
While the first theory was initially focused on the speed of information processing 
theory (Salthouse, 1996; Cerella, 1990) and later evolved addressing a cognitive 
resources decline as unifying metaphor of cognitive ageing, the other two theories are 
closer to the concept of executive functions (EF) or executive control. In fact, Craik & 
Byrd (1982) proposes an age-related deficiency in on-line processing resources and 
attentional capacity, suggesting that older adults are lacking in the ability to engage self-
initiated processes, which require conscious effort and are typically considered EF. At 
the same time, Hasher and Zacks (1988) emphasize the age-related changes in focussing 
on target information, and in inhibiting attention to irrelevant material; They sustained 
that the inhibitory control represents a fundamental variable to understand cognitive 
ageing (Hasher & Zacks, 1988). 
Specific models, which do not have the aim to find a unifying metaphor, are represented 
by single domain theories. These models report and sustain age-related changes in 
particular classes of cognitive functions such as memory (Schacter et al., 2012; Light, 
2000-1991; Jacoby, 1999; Kensinger & Schacter, 1999) or EF (Butler et al., 2004; Mayr 
et al., 2001; Johnson & Raye, 2000; Hasher & Zacks, 1988).  
As this short review of the current theoretical status suggests, the concept of EF is a 
recurring theme in CPA. EF have been invoked more than once to explain ageing-
related cognitive changes, as a specific target of deficit (Butler et al., 2004; Mayr et al., 
2001; Johnson & Raye, 2000) or as a general underlying mechanism whose dysfunction 
can justify specific deficits in other domains (Salthouse, 1996; Cerella, 1990; Hasher & 
Zacks, 1988; Craik & Byrd, 1982). However, these theories have tried to give an 
explanation of cognitive ageing without any link to brain ageing. In this regard, 
cognitive neuroscience of ageing is aiming to specifically link cognitive ageing to brain 
ageing. 
2.2	  Executive	  functions	  in	  cognitive	  neuroscience	  of	  ageing	  	  
Until recently, the cognitive and neural mechanisms of age-related changes in cognition 
were studied independently of each other (Cabeza et al., 2005). Research on CPA has 
the aim to investigate age related changes on cognition and behaviour, while 
neuroscience of ageing investigates age related modifications on the anatomy and 
physiology of the brain.  
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The emergence of a relatively new discipline, cognitive neuroscience of ageing (CNA), 
represents the need to link the effects of ageing on cognition with the effects of ageing 
on the brain. Although the link between cognitive and brain impairments in ageing 
seems quite obvious, the nature of these brain-behaviour relationships is still largely 
unknown (Cabeza et al., 2005). In fact, mapping cognitive operations onto neural 
circuitry is a challenging task, not only because cognitive theories can lack precision or 
can be conflicting, but also for several biological and methodological limits (for a 
review see Hedden & Gabrieli, 2004). First of all, from a biological point of view 
ageing is strongly associated with risk for numerous pathologies: even when working 
with highly selected healthy older adults, research indicates that normal ageing is 
associated with changes in the neural basis of cognition (Hedden & Gabrieli, 2004). 
Secondly there are also two methodological factors. The first one is the use of 
correlational analysis. This kind of analysis is used because age cannot be 
experimentally manipulated, but at the same times it leads to a lack of causal relations 
in the results. The second is the employment of cross-sectional comparisons between 
age groups, method justified by the cost and the complexity of longitudinal research, 
but that provides valid but less reliable results. Finally, the combination of these limits: 
many brain and mental changes can occur in parallel during ageing, and the most 
common methodological approaches make it difficult to establish reliable relations. 
In spite of these challenges, advances in neuroimaging techniques have helped to deal 
with some of these limits and they have allowed the elaboration of different theories and 
subsequent models (Cabeza et al., 2005). Specifically, it is possible to distinguish two 
classes of models: models that refer to age related changes in hemispheric lateralization, 
and models that focus on an age related anterior-posterior asymmetry. Two main 
models represent the first class. The right hemi-ageing model, which states that the right 
hemisphere is more sensitive to the harmful effects of ageing then left hemisphere 
(Dolcos et al., 2002). This model is primarily based on behavioural rather then 
neurobiological data and this lack of evidences stimulated the elaboration and the 
advancing of a second model, known as HAROLD (Hemisphere Asymmetry Reduction 
in Older Adults; Cabeza, 2002). HAROLD model states that, under similar conditions, 
the activity of the prefrontal cortex (PFC) tends to be less lateralized in older than in 
younger adults (Cabeza, 2002): elderly are more likely to rely on both hemispheres in 
condition in which unilateral recruitment is sufficient in young adults (Daselaar & 
Cabeza, 2005).  
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Describing the HAROLD model, Cabeza (2002) explained the smaller lateralization in 
older adults invoking a compensation mechanism. In fact, the cooperation between the 
two hemispheres is more advantageous than a within-hemisphere processing in 
situations of high task demand (Weissman & Banich, 2000; Brown & Jeeves, 1993; 
Banich & Belger, 1990). Following this explanation, older adults that experience higher 
task demands, respect to younger adults, would show a greater hemispheric 
collaboration and a smaller lateralization in the activity of the PFC. Findings in support 
of the HAROLD model (Cabeza, 2002) are numerous and have specially been reported 
in the domains of working memory, attention, and inhibitory control processes. Data 
supporting this theory refer on several experimental evidences (Daselaar et al., 2003; 
Rosen et al., 2002; Reuter-Lorenz et al., 2000; Rypma & D’Esposito, 2000). 
In the second class of models, i.e. models that take into account age related anterior-
posterior asymmetry, the Frontal Lobe Hypothesis (FLH) formulated by West (1996) 
represents a dominant view and probably one the most accredited theory. According to 
the FLH, cognitive processes supported by the PFC will manifest age-related decline at 
an earlier age and in greater magnitude, than cognitive processes supported by non-
frontal regions (West, 2000; West, 1996). This theory states that, due to differential age 
related decline of neural tissue in the PFC, cognitive functions supported by these areas 
are more susceptible to age effects than functions that rely on posterior and subcortical 
areas (Band et al., 2002). There are many functional and structural neuroimaging studies 
that support this theory.  
According to past and recent findings, ageing effects on the PFC consist in a decreasing 
of myelin (Albert, 1993), white matter degeneration (Raz et al., 2005; Guttmann et al., 
1998), decreased neurotrasmettitorial response (Fulop & Seres, 1994) and decreasing 
metabolic activity (Uylings et al., 2000; West, 1996; Salmon et al., 1991). Even if these 
data support the FLH theory, common critics to this model include the fact that it is 
supposed to be based on both weak and conflicting neuroimaging evidences (Band et al., 
2002; Greenwood, 2000; Wickelgren, 1996) and on behavioural data based on 
measurements that may be sensitive to more dysfunctions than only that of the PFC 
(Band et al., 2002). 
These criticisms are strictly linked to a main issue described in the previous chapter: the 
fact that defining frontal lobes functions and EF neural correlate is a really difficult task.  
	   25	  
This complexity reflects on one hand the definition of the functions subjects to decline 
and, on the other hand, the functional meaning of brain changes. Ideally, to refine this 
hypothesis, that is still one of the most accredited, research should consider all the 
neural networks and the functional activity of the circuitries in which frontal regions are 
involved (Tisserand & Jolles, 2003). This is exactly what the current trend of research 
in CNA is aiming to do. In fact the new neuro-computational approaches suggest that 
“ageing related changes in the dynamical properties of cortical functions could be 
related not only to neuroanatomical degeneration, but also declines in neurochemical 
processes affecting pattern representation and information transfer within and between 
cortical regions” (Daselaar & Cabeza, 2005).  
One of the most recent hypotheses in CNA suggests that cognitive ageing may be 
related to principal decline of dopaminergic modulation in both PFC and different 
subcortical regions (for a review see Bäckman et al., 2010-2006). Even if details 
regarding the involvement of neuro-modulation in cognitive ageing deficits remain to be 
investigated, this recent hypothesis is based on the integration of many evidence. 
Together with findings about the primary PFC involvement and about age-related 
decline of EF (Daselaar & Cabeza, 2005), several evidence sustain the presence of a 
deficient dopaminergic modulation in ageing. This last finding is important because of 
shared knowledge about the relation between dopamine (DA) and cognition. Recent 
researches, in fact, suggest that DA has not only a central role in motor functioning but 
is also critically implicated in higher-order cognitive abilities (Bäckman et al., 2006). 
Studies on clinical populations with severe alteration of DA system, such as Parkinson’s 
disease (PD) and Huntington’s disease (HD), indicated that patients showed deficits 
across multiple cognitive domains, including EF (Kudlicka et al., 2011; see also Brown 
& Marsden, 1990; Brandt & Butters, 1986). Furthermore animal study evidence have 
shown an association between the degeneration of dopaminergic pathways and deficits 
in memory (Simon et al., 1986), inhibition (Jones & Robbins, 1992), spatial attention 
(Boussaoud & Kermadi, 1997) and set-shifting (Robert et al., 1994). An important role 
in supporting this theory is played by pharmacological studies on humans and animals, 
which have found that the manipulation of DA transmission may be related to cognitive 
performance in working memory tasks (Kimberg & D’Esposito, 2003; Mattay et al. 
2003; Mehta et al., 2000; Luciana et al. 1998-1992; Luciana & Collins, 1997) and in the 
speed of information processing (Ramaekers et al., 1999; Halliday et al., 1994).  
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Similar results were found in genetic research. It was demonstrated that performance 
enhancement in working memory task emerged after the inhibition of COMT (Kneavel 
et al., 2000, Gogos et al., 1998; Gasparini et al., 1997; Liljequist et al., 1997) an enzyme 
that inactivates extracellular DA especially in the PFC.  
Given these consistent evidences, it is possible to confirm the existence of a relation 
between DA and cognition: this is an important assumption in the light of the numerous 
evidences about age-related losses of dopaminergic functioning. Specifically, there is 
extensive evidence for a main age-related loss in various biochemical markers of the 
nigrostriatal DA system, both post-synaptic markers as DA receptors (Ichise et al., 
1998; Wang et al., 1998; Antonini et al., 1993; Suhara et al., 1991; Rinne et al., 1990; 
Cortes et al., 1989; Seeman et al., 1987; Severson et al., 1982;) and pre-synaptic as DA 
transporters (Ma et al., 1999; Rinne et al., 1998; Bannon & Whitty, 1997; Van Dyck et 
al., 1995; Bannon et al., 1992; Allard & Marcusson, 1989).  
Without going into detail of this specific literature, the main point to highlight is that 
these two kinds of finding have a complementary role in the study of cognitive ageing. 
The decline of both DA markers and cognitive efficiency with advancing age, together 
with the findings about the role of DA on cognition, have stimulated the examination of 
a relationship between age-related changes in DA functioning and age-related changes 
in cognition (Daselaar & Cabeza, 2005). To explore this connection, a modelling 
approach is going to be adopted. This approach is integrating the empirical evidences 
about the role of dopamine in cognitive functioning into neuro-computational models. 
The work of Li and colleagues (2001) is particularly relevant as, by modifying a 
previous model (Servan-Schreiber et al. 1998), they elaborated a model in order to link 
age-related cognitive deficits to deficient dopaminergic modulation. The model 
accounts for an inverted U-shaped dose–performance function (see figure 2.1) by 
demonstrating that a normal cognitive performance is related to optimal DA levels, 
while extremely low or high DA levels result in poorer cognitive performance (Li & 
Sikström, 2002; Li et al., 2001). As recently suggested by Vaillancourt and colleagues 
(2013), the interpretation of this interesting model (Li et al., 2001) should be integrated 
taking into account many other factors that could contribute to this inverted U relation, 
such as the regional striatal topography of nigrostriatal denervation, the individual 
genetic factors that can affect dopaminergic functions itself, determining the relative 
baseline position on this inverted-U curve.  
	   27	  
	  
However, from this model it is possible to extract an important assumption: while a 
normal cognitive performance is associated to an optimal dopamine level, a poor 
cognitive functioning is related to irregular dopamine levels, both lower and higher than 
normal, i.e. a dopamine dysregulation. 
 
	  
 
FIGURE 2.1: inverted U-shaped function linking the efficacy of DA signalling in early and 
late adulthood cognitive performance. Baseline position is determined by different factors, 
as genotype. (Adapted from Nagel et al., 2008) 
  
Taken together, these findings suggest that patterns of age brain changes, such as the 
declines of dopaminergic modulation in the PFC and in linked subcortical regions, 
could be associated with age related deficits in EF. However this is a recent point of 
view ad many specific mechanisms of neuro-modulation in cognitive ageing deficits 
remain to be investigated.  
2.3	  Executive	  functions	  in	  ageing:	  current	  view	  	  
As mentioned previously, the elaboration of cognitive ageing theories were always 
based on the empirical observation. Firstly inspired by cognitive theories, then by 
neurocognitive theories, every model represents the effort to explain the behavioural 
data collected, interpreting cognitive changes related to ageing.  
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With this aim both the FLH (West, 1996) first, and the neuromodulation hypothesis in 
recent times, have tried to explain cognitive ageing phenomenon focusing on the neural 
basis of consistent behavioural data. In fact, both these perspectives have focused on 
evidence of an EF involvement in the manifestation of age-related cognitive deficits. 
They are based on the assumption that the disruptions of the executive control might 
affect performance in a wide variety of cognitive tasks (Salthouse et al., 2003) and, 
integrating behavioural and neuroimaging data, suggested coherent and convincing 
models.  
However, the complexity of the issues involved in this theoretical challenge brings 
inevitably to a prickly situation. West himself proposed a refinement of FLH, following 
the identification of differential age-related decline within the PFC, and suggesting the 
exploration of differential ageing effects on the various cognitive processes supported 
by the PFC (West, 2000). Following this aim, current research directions are oriented to 
the identification of age-related changes in executive sub-processes. As interestingly 
summarized by Verhaeghen (2011), the actual question is not, “Are there age-related 
differences in executive control?” but it became “Are there unique (i.e. specific) age-
related deficits in executive control?”. To answer this question, research efforts are now 
directed to explore age-related changes in specific EF subcomponents.  
Even in this case, discrepant results are expected, as natural consequence of the 
complexity of EF concept. However, new investigations in this field are necessary to fill 
the lack of consistent results on the pattern of ageing effect on EF (for a review see 
Verhaeghen, 2011).  
Therefore the main goal of the three studies reported in this thesis is to explore age 
differences in specific EF subcomponents to better understand age-related cognitive 
changes. Specifically, we chose to explore EF as working memory, reward based 
learning and outcome monitoring, abilities that, according to the literature, are also 
associated with the dopaminergic activity in the PFC (Bäckman & Farde, 2005; see also 
Hämmerer & Eppinger, 2012; Bäckman et al., 2010-2006). 
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CHAPTER	  III	  
PARKINSON’S	  DISEASE	  AND	  EXECUTIVE	  FUNCTIONS	  
	  
Parkinsonism is a syndrome that is clinically defined by the presence of motor features, 
particularly tremor at rest, rigidity, bradykinesia, and gait and postural abnormalities. 
The most common form of Parkinsonism is the idiopathic variety known as Parkinson’s 
disease (PD). PD is now the second most common neurodegenerative disorder after 
Alzheimer's disease, with a reported overall incidence rates between 9 and 22 per 
100,000 person-years in Europe (Wirdefeldt et al., 2011). 
PD was firstly recognised as a unique clinical syndrome by James Parkinson in his 
work: ‘Essay on the Shaking Palsy’ (1817). In this essay Parkinson stressed the crucial 
role of motor impairments in the defining pathology of PD. This first description has 
influenced following studies and made PD traditionally considered a motor system 
disorder. Thank to several research and clinical reports, PD is now considered to be a 
much more complex syndrome involving motor as well as non-motor systems (Jankovic, 
2007). In this chapter, after a brief explanation of neural pathophysiology of PD, 
cognitive symptomatology developed by PD patients will be described, focusing in 
detail on the executive dysfunctions.  
 
3.1	  Neural	  pathophysiology	  of	  Parkinson’s	  disease	  
 
The main pathologic feature of PD, and essential for its diagnosis, is the loss of 
dopaminergic neurons of the substantia nigra pars compacta, one of the structures of the 
basal ganglia (BG). The BG is set of interconnected subcortical nuclei, which represent 
a key part of the extrapyramidal motor system and that are also involved in motivation 
and cognitive functions.  
BG activity is the result of a complex circuit, in which the primary input nucleus is the 
striatum, tha includes both putamen and caudate nucleus. The striatum, in fact, receives 
excitatory afferents from the cortex and thalamus, as well as dense innervation from 
midbrain DA neurons, and represents a major site of synaptic plasticity in the BG 
(Gerdeman et al., 2003; Bolam et al., 2000; Gerfen, 2000; Wilson, 1998).  
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BG circuit is based on the segregation of information processing into a direct and an 
indirect pathway (figure 3.1), which act in opposing ways to control movement 
(Kreitzer & Malenka, 2008). These two pathways represent two parallel cortex-BG-
thalamus-cortex loops, which diverge within the striatum and are differentially 
modulated by DA.  
The net effect of direct-pathway activity is the facilitation of movement, while the net 
effect of indirect-pathway activity is the inhibition of movement.  	  
	  
 
FIGURE 3.1: schematic organisation of the Basal Ganglia. GPi: internal globus pallidus; 
GPe: external globus pallidus; SNr: substantia nigra pars reticolata; SNc: substantia 
nigra pars compacta; dp: direct pathway; ip: indirect pathway. In blu are represented 
glutamatergic (Glu) structures, in red the GABAergic (GABA) nuclei and in yellow the 
dopaminergic (DA) nucleus. (Fino & Venance, 2010)  
 
 
In PD the loss of DA neurons in the substantia nigra, that could reach 60% even in 
mildly affected PD patients, accounts for the approximately 80% loss of DA in the 
striatum (Zigmond & Burke, 2002). This means that one of major dopaminergic 
pathways in the human brain, the nigro-striatal pathway, is compromised in PD. This 
impairment brings to an overall dysfunction of the BG activity and results in the typical 
motor symptomatology of PD (see table 3.1). 
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TABLE	  3.1	  Motor	  manifestations	  of	  Parkinsonism:	  *Cardinal	  signs	  of	  PD.	  
	  
Tremor	  at	  rest*	  
Rigidity*	  
Bradykinesia*	  
Loss	  of	  postural	  reflexes*	  
Hypomimia	  (masked	  facies)	  
Speech	  disturbance	  (hypokinetic	  dysarthria)	  
Hypophonia	  
Dysphagia	  
Sialorrhea	  
Respiratory	  difficulties	  
Loss	  of	  associated	  movements	  
Shuffling,	  short-­‐step	  gait	  
Festination	  
Freezing	  
Micrographia	  
Difficulty	  turning	  in	  bed	  
Slowness	  in	  activities	  of	  daily	  living	  
Stooped	  posture,	  kyphosis,	  and	  scoliosis,	  
Dystonia,	  myoclonus,	  orofacial	  dyskinesia	  
Neuro-­‐ophthalmologic	  findings	  
Impaired	  visual	  contrast	  sensitivity	  
Visuospatial	  impairment	  
Impaired	  upward	  gaze,	  convergence,	  and	  smooth	  pursuit	  
Impaired	  vestibuloocular	  reflex	  
Hypometric	  saccades	  
Decreased	  blink	  rate	  
Spontaneous	  and	  reflex	  blepharospasm	  (glabellar	  or	  Myerson’s	  sign)	  
Lid	  apraxia	  (opening	  or	  closure)	  
Motor	  findings	  related	  to	  dopaminergic	  therapy	  
Levodopa-­‐induced	  dyskinesia	  (chorea,	  dystonia,	  myoclonus,	  tic)	  
(from Jankovic, 2007) 
 
The loss of dopaminergic neurons and the consequent impairment of BG activity do not 
affect only motor functions. As mentioned above, BG are not only involved in motor 
regulation: several researches suggest that BG activity is also related to a variety of 
cognitive functions, especially working memory and learning abilities (for recent 
reviews see Helie et al. 2013; Steiner & Tseng, 2010). Furthermore, neuron loss in 
substantia nigra also involves extrastriatal regions. In fact, DA depletion in nigrostriatal 
pathway affects functionality of the principal target of basal ganglia outflow, i.e. the 
frontal lobes. The striatum is in fact connected with several areas of the frontal lobes, 
beyond the motor areas, such as the dorsolateral prefrontal cortex, the lateral and medial 
orbitofrontal cortex and the anterior cingulate cortex.  
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In detail, four fronto-striatal circuitries have been described. Each circuitry starts in a 
specific region of the frontal cortex and innervates different levels of the striatum before 
being relayed back to its cortical origin, via the thalamus. The activity of these circuits 
was related to specific functional outcomes, beyond the motor functioning. While the 
dorsolateral circuit is associated with high level cognitive functioning, i.e. executive 
functions (EF), the third and the fourth circuits were related to mood and behavioural 
regulation (see chapter 1). The original neuron loss in the substantia nigra and then in 
the striatum inevitably influences the functioning of these circuits and leads to a 
complex pattern of functional consequences in PD patients. 
In addition to the dysfunction of nigro-striatal and fronto-striatal connections, the DA 
depletion in the substantia nigra also affects another important dopaminergic 
transmission, represented by the meso-cortico-limbic dopaminergic pathways. In these 
pathways, DA is transmitted from the ventral tegmental area, located in the midbrain, to 
several cortical and subcortical structures (see figure 3.2). In detail the following 
structures are considered to be part of the meso-cortico-limbic dopaminergic pathways: 
the limbic system, the nucleus accumbens, i.e a structure located in the ventral striatum, 
the amygdala, the hippocampus and the medial prefrontal cortex. This complex 
dopaminergic transmission is considered one of the most important anatomical 
substrates of reward processing and, consequently, of mood and motivational regulation 
(Wise, 2002-1998; Willner, 2001).   
  
     
 
 
 
 
 
 
FIGURE 3.2: dopaminergic pathways in the human brain (from Fuster, 2008). 
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In PD, this pattern of both subcortical and cortical dopaminergic dysfunction is also 
accompanied by the impairment of different neurochemical systems and neural 
circuitries. Neuron loss is in fact not restricted to the dopaminergic neurons. Other 
catecholaminergic cell groups, including the locus coeruleus, are involved, and also 
some cells of the sympatho-adrenal system and the serotoninergic neurons of the raphe 
nuclei are subject to impairment. Furthermore, a loss of cholinergic neurons in the 
nucleus basalis of Meynert was also described in PD (for a review see Bohnen & Albin, 
2011).  
Finally, the cell loss is also accompanied by the presence in the remaining neurons of 
Lewy bodies, abnormal aggregates of protein that represent another common feature in 
this pathology.  For all of these reasons, even though the DA deficit is a hallmark of this 
neurodegenerative disorder, it is now generally accepted that PD has a widespread 
effect in all the nervous system. This extensive involvement can explain the 
multifaceted symptomatology of PD and it supports the idea that motor symptoms 
represent only an aspect of this pathology. In fact, even if the diagnosis of PD requires 
that two of the four primary motor symptoms are present (see table 1) and respond to 
anti-parkinsonian medication (Jankovic, 2008), non-motor manifestations represent a 
common feature of PD (see table 3.2). Furthermore, some of these non-motor 
manifestations may actually precede the motor dysfunction (Bonnet & Czernecki, 2013; 
Dickson et al., 2009). 
 
Table	  3.2	  Principal	  non-­‐motor	  features	  of	  Parkinson’s	  disease.	  
	  
Autonomic	  dysfunction	  
Cognitive	  deficits	  
Mood	  disorders	  
Behavioural	  disorders	  
Dementia	  and	  psychosis	  
Sleep	  disorders	  
Olfactory	  dysfunction	  
Restless	  legs	  syndrome	  	  
Pain	  
(adapted from Poewe, 2008) 
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Of the vast range of non-motor symptoms, cognitive problems can have a significant 
impact on the quality of life of PD patients. Research in this field is currently aiming to 
explore the origins and the exact manifestation of these problems, and studies are 
investigating the potential role of dopaminergic medications in the development of both 
cognitive and behavioural complications (Vaillancourt et al., 2013; Tang & Strafella, 
2012). 
 
3.2	   Cognitive	   deficits	   in	   Parkinson’s	   disease:	   the	   role	   of	   executive	  
functions	  
 
Even if James Parkinson described PD as a condition in which “the senses and intellect 
being uninjured”, now PD is clearly associated with the development of cognitive and 
behavioural problems. Exploring cognitive functions in PD patients, the severity of the 
impairment ranges from difficulties in a single domain, through global decline and 
dementia. In PD different cognitive domains may be impaired, including memory, 
language, attention, visuospatial and visuo-constructive abilities, and executive 
functions (EF) (Zgaljardic et al., 2003).  
According to literature, the most part of cognitive deficits reported in PD may actually 
be the manifestation of an underlying executive dysfunction, which seems to be the 
most important cognitive impairment in this neurodegenerative disease (for reviews see 
Dirnberger & Jahanshahi, 2013; Parker et al., 2013; Kudlicka et al., 2011). EF deficits 
affect roughly 30% of PD patients (Parker et al., 2013; see also Aarsland and Kurz, 
2010; Williams-Gray et al., 2009) and are considered as predictors of dementia onset in 
this clinical population (Aarsland & Kurz, 2010; Mahieux et al., 1998; Levy et al., 
2002a-b; Janvin et al., 2005). Furthermore, EF deficits are associated with considerable 
morbidity (Williams-Gray et al., 2007) and seem to predict future mortality of PD 
patients (Forsaa et al., 2010; Santangelo et al., 2007). Even thought such deficits can 
occur early in the disease (Aarsland et al., 2009; Foltynie et al., 2004) and are linked 
with gait-disturbance (Wylie et al., 2012), they are not directly correlated with motor 
dysfunctions (Van Spaendonck et al., 1996). The results of a recent meta-analysis 
provide consistent evidence for PD impairment of EF as cognitive flexibility, set 
switching, inhibition and working memory (Kudlicka et al., 2011).  
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This is not surprising since the above-mentioned degeneration of fronto-striatal 
connections in PD. Specifically, these evidences are coherent with the impairment of 
the circuitries that link striatum with the prefrontal cortex, especially the dorsolateral 
one (Owen, 2004). 
Moreover, a different class of EF are also impaired in this clinical condition. PD 
patients fail in appropriate decision-making on the basis of positive and negative 
outcomes, making less profitable decisions (Mimura et al., 2006) and showing an 
overall impairment in the reward driven goal-directed behaviour (Ravizza et al., 2012). 
This kind of EF impairment has been related to an anomalous reward processing, a 
deficit that has been documented in PD patients (Kapogiannis et al., 2011; Kobayakawa 
et al., 2010; Bodi et al., 2009; Rutledge et al., 2009; Frank et al., 2007-2004; Goerendt 
et al., 2004; Künig et al., 2000). 
While the first class of EF impairment was associated with a dysfunctional dorsolateral-
striatal-circuitry, this kind of cognitive disorders are mostly associated with different 
fronto-striatal circuitries as well as with the degeneration of the meso-cortico-limbic 
dopaminergic systems.  
Despite this pattern of results is based on a large amount of evidences, research of EF 
deficits in PD is still characterized by different challenges.  
From one hand, the complex nature of the EF construct, together with the low validity 
and reliability of EF tests can give reason of contradictory reports in the literature about 
EF, and in research about EF in PD (Kudlicka et al., 2011). From the other hand, the 
clinical heterogeneity and the complex pathology of PD was often considered as 
responsible for this inconsistent literature. Current research is now highlighting the 
importance of another factor, i.e. the dopaminergic therapy commonly used for the 
treatment of motor symptoms in PD. 
Motor symptoms of PD are in fact mostly treated with a pharmacological therapy that 
replaces the lack of DA. Even if a definition of the best pharmacological management in 
this pathology is still matter of debate (Worth, 2013), Levo-dopa represents the goal-
standard in the treatment of PD (Pilleri & Antonini, 2014), being the most effective 
pharmacologic agent and the primary treatment for symptomatic patients (Rao et al., 
2006). Levo-dopa is a metabolic precursor of DA that crosses the blood-brain barrier, is 
converted in DA and acts as a replacement of the dopaminergic lack.  
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Due to side effects of a prolonged administration (for details about “long-term levodopa 
syndrome” see Factor, 2007), levo-dopa is usually prescribed with adjunctive therapies, 
of which DA-agonists represent the most common. Without going into details about 
chemical aspects, one common feature of these pharmacological therapies is the action 
on the DA system that improves the functioning of DA neurons activity.  
Recent studies have found that the dopamine replacement therapy (DRT) classically 
ameliorates motor deficits in PD, but it can also affects on non-motor manifestation of 
PD, such as cognitive deficits. Evidence report that DRT could improve and impair the 
cognitive performance of PD patients (Kulisevsky et al., 2007-1996; Robbins, 2005; 
Cools et al., 2003-2001; Kulisevsky, 2000) and this double effect seems to be dependent 
on several factors. For example, DRT effects on cognitive functions could be different 
depending on the individual DA genotype, which is related to the individual differences 
in the response to the DRT. Additionally, DRT effects on cognitive functions are due to 
the different levels of DA depletion in different brain areas. In detail, the fact that a 
more pronounced reduction of DA	  concerns the dorsal than the ventral striatum in PD 
(Kish et al., 1988) can bring to differential effects of the DRT on the neural circuits that 
involve these regions. In this way, therapies that restore dopaminergic level in the dorsal 
fronto-striatal connections could result in a dopamine “overstimulation” in the ventral 
fronto-striatal connections, bringing to differential effects on the cognitive functions 
related to those circuits. Coherently with this assumption, recent findings suggest that 
while DRT ameliorates the performance in the tasks associated with the dorsal fronto-
striatal circuitry (Sohn et al., 2000), it impairs the performance in the task related to 
relatively less compromised areas, as the ventral fronto-striatal one (Cools et al., 2003). 
Particularly, several evidence reported that patients with mild to moderate disease are 
impaired in planning and task switching when DRT is withdrawn (‘off’ state), but they 
are not impaired on risk-taking paradigms or probabilistic reversal learning (Foltynie et 
al., 2004a,b; Cools et al., 2003-2001; Lewis et al., 2003; Swainson et al., 2000; Gotham 
et al., 1988). On the contrary, when treated with dopaminergic agents (‘on’ state) 
planning and task-switching deficits improved, but PD patients become impaired on 
risk-taking, gambling and reversal learning paradigms (Pagonabarraga et al., 2007; 
Voon & Fox, 2007; Mimura et al., 2006; Brand et al., 2004; Cools et al., 2003-2001; 
Molina et al., 2000; Swainson et al., 2000) and manifests feedback processing 
abnormalities (Kapogiannis et al., 2011; Bodi et al., 2009; Kobayakawa et al., 2010; 
Frank et al., 2007-2004). 
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These results seem to be consistent with the “dopamine overdose hypothesis” (Cools et 
al., 2001; Swainson et al. 2000; Gotham et al., 1988), which suggests the presence of a 
DA overstimulation by DRT in the relatively intact DA-dependent brain regions.  
Even if cognitive functions have been the major focus of research about the dopamine 
overdose hypothesis, overstimulation by DRT has been also related to the development 
of impulse control disorders (ICDs) in PD patients. According to the DOMINION study 
(Weintraub et al., 2010), most frequent ICDs in PD patients under DRT are compulsive 
shopping, pathological gambling, binge eating and hyper sexuality. The development of 
these disorders, by around 15% of medicated PD patients (Callesen et al. 2013), has 
been linked to the overstimulation of the mesolimbic dopaminergic system (Cools & 
Robbins 2004). In detail, several lines of evidence point toward a reduced sensitivity of 
the reward system as a key feature in the development of ICDs by PD patients under 
DRT (for a review see Callesen et al. 2013). Linking cognitive deficits to these 
behavioural outcomes, it could be reasonable that feedback-processing deficits 
generally result in aberrant expectations of reward and loss and, consequently contribute 
to the development of pathological behaviour as ICDs.  
The exploration of DRT effect on cognitive functions of PD patients is object of several 
investigations, with particular interest in the understanding of the relation between EF 
deficits and dopaminergic treatment (for a review see Vaillancourt et al., 2013). 
In our opinion, in stead of “overdose”, the term “dysregulation” better describes the 
complex DA functionality in PD, and better summarizes the positive and the negative 
results of the complex interaction between individual differences, pathological factors 
and pharmacological treatment.  
The above described findings of PD-related deficits in working memory, planning, 
inhibition and task- or set-switching, as well as in reward based control of behaviour, 
represent a set of evidence that should still be explored and investigated, trying to better 
define the EF profile of medicated PD patients. This is the goal this thesis. Aim of the 
three studies that will be presented is to investigate EF deficits in medicated PD patients, 
trying to add evidence and to improve our understanding by employing new 
methodological approaches.  	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CHAPTER	  IV	  -­‐	  FIRST	  STUDY	  
EXECUTIVE	  FUNCTIONS	  AND	  WORKING	  MEMORY:	  INTERFERENCE	  AND	  
FACILITATION	  EFFECTS	  IN	  AGEING	  AND	  IN	  PARKINSON’S	  DISEASE	  
	  
4.1 	  Introduction	  	  
Working memory (WM), as proposed by Baddeley (Baddeley & Hitch, 1974; Baddeley, 
1986), is a powerful explanatory concept that includes some of the fundamental 
properties of short term memory, like the capacity to store information for a brief period 
of time, together with the presence of a superordinate control system that permits the 
use of stored information in the service of complex cognitive tasks. According to one of 
the most adopted models in cognitive psychology (Baddeley 2000-1986) WM is 
described as the implementation stores and rehearsal processes of short term memory, 
that maintain information in active state, and executive processes that enable work to be 
done with the stored contents (Miyake & Shah, 1999). This kind of model is not 
contrasting with functional neuroimaging studies, which interpret WM process as the 
result of an interaction across different brain regions in extended networks. WM 
performance would reflect the integration of “top-down” signals from prefrontal cortex 
(PFC) and posterior brain regions (Desimone & Duncan, 1995), contributing to the 
encoding, maintenance, and retrieval of representations in WM (Sander et al., 2012; 
Miller & Cohen, 2001). 
Both cognitive and neurocognitive models agree in defining WM performance as the 
“outcome of processing at multiple hierarchical levels, including the analysis of low-
level features and their integration or binding into higher-level representations in 
interaction with top-down control processes to reconstruct a stable mental 
representation of previously experienced information” (Ranganath, 2006). This tight 
integration of the storage and processing components of the WM system provides 
functionality in higher cognitive domains, such as planning, problem-solving, and 
reasoning (Braver & West, 2008). 
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The research on WM has mostly upheld these assumptions but this concept is still 
evolving, especially in terms of exploration of the mental operations that make up the 
central executive (Smith & Jonides, 1999; Goldman-Rakic, 1995; Petrides, 1994). 
Despite the complex issue of defining executive function (EF), according to Reuter-
Lorenz and Sylvester (2005) there is a common agreement in taking into account at 
least four key processes crucial to the “top-down” operations of WM: executive 
attention, that focuses resources on task relevant information and inhibition, that 
suppresses irrelevant information and resolves interference and conflict; task 
management, i.e. the ability to maintain a goal and organize sub-goals and, finally, set 
shifting which refers to the ability to change rule states and decision criteria.  
Following the current challenges in defining the precise role of such executive 
operations in WM, goal of the present study is to examine mostly the role of executive 
attention and inhibition components. We propose a new task, which aims at exploring 
the focusing of attention on the WM representations, referring to studies that showed as 
selective attention operates in a similar way to both perceptive and symbolic 
representations (Chun, 2011; Cherubini et al., 2007; Cherubini et al., 2006). More 
precisely, we translated a classical paradigm used for the study of attention, the Stroop 
task (Stroop, 1935), in a WM task, using symbolic instead of perceptual stimuli. In 
detail, the task was designed using condition-action rules as stimuli, and supposing that 
an irrelevant bi-conditional rule (“if X occurs, then do Y; otherwise do Z”), transiently 
encoded in WM, can affects the use of a similar task-relevant rule that is also stored in 
WM. Setting up two congruence conditions, as happens with the stimuli of the Stroop 
task, incongruence between the two rules should cause significant interference effects 
measured as delays in reaction times (RT) and lower accuracy, while a congruence 
should result in facilitation effect, i.e. faster RT and higher accuracy.  
In the present study we propose the application of this new WM task in healthy young, 
adults and older people and in a sample of Parkinson’s disease patients under 
dopaminergic treatment.  
First aim of this study is to explore the top-down components of WM, investigating 
how executive attention and inhibition works in the management of symbolic 
information in WM. Secondly, this study aims at exploring ageing effects on these WM 
components, supposing that age-related changes in EF would increase vulnerability to 
interference also in WM (see Reuter-Lorenz & Sylvester, 2005).  
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Literature about WM and ageing strictly refers to the Baddeley structural distinction 
between the storage buffers and executive control components. It shows that the tasks 
which seem to tap best into the function of WM storage buffers show minimal age-
differences while, the so-called complex span tasks, which require the coordination of 
short-term storage with the processing capacity of the executive controller, do show 
robust and reliable age-differences (Bopp & Verhaeghen, 2007; Bopp & Verhaeghen, 
2005; Babcock & Salthouse, 1990). Recent WM literature is advising the use of other 
forms of testing along with span tasks for the measure of age-related cognitive decline 
in executive control processes of WM (Braver & West, 2008). In our opinion, our task 
follows this suggestion, exploring executive components of WM without focusing on a 
span measure. Finally we will investigate if, and how, top down components of WM are 
impaired in medicated PD patients, on the base of knowledge about the primary role of 
the dopaminergic frontal-basal connection in the filtering of irrelevant information in 
WM (Baier et al., 2010; McNab & Klingberg, 2008; Moustafa et al., 2008; Vogel et al., 
2005; Frank et al., 2001; Goldman-Rakic, 1996) and basing on empirical findings about 
reliable impairments of PD patients in WM task (Lewis et al., 2005; Owen, 2004; Owen 
et al., 1997; Cooper et al., 1991). In detail, these impairments refer to a significantly 
lower WM span compared to healthy subjects (Fournet et al., 2000; Stebbins et al., 
1999; Fournet et al., 1996; Gabrieli et al., 1996). The findings are also accompanied by 
neuroimaging data that support the hypothesis of a negative relation between basal 
ganglia (BG) activity and WM impairment in PD patients (Lewis et al., 2003; Owen et 
al., 1998) and indicate an involvement of BG in WM tasks in healthy subjects (Chang et 
al., 2007; Monchi et al., 2000). Even in the study of clinical samples, research efforts 
are moving towards the separation of executive components and the storage capacity of 
WM; this trend is followed by both behavioural and neuroimaging studies. For what 
concerns the study of WM in PD patients, this current trend is also accompanied by the 
exploration of the role of DA medication, that might either enhance or impair 
performance in PD patients (for a review see Moustafa et al., 2008). 
In conclusion, we will explore the executive components of WM, precisely executive 
attention and inhibition, investigating these cognitive functions in healthy ageing and in 
Parkinson’s disease. To reach these goals we proposed our new task to three groups of 
healthy people, one represented by young participants (19-27 years), one represented by 
adults (55-66 years) and one by older subjects (68-80 years), and to a fourth group of 
medicated PD patients, matched for age, sex and education with the older subjects.  
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4.2 	  Method	  	  
Participants	  
A total of sixty-two healthy participants were recruited in this study: twenty young (7 
M; age range 19-27 years; mean= 23.5 sd=2.3) twenty-two adults (13 M; age range 55-
66 years, mean= 61.7 sd=3.1) and twenty older subjects (11 M; age range 68-80 years, 
mean= 71.9 sd=2.5) took part in the experiment. Twenty PD patients (12 M; age range 
56-77 years, mean=69.3 sd= 5.9) were also recruited in the Neurology division of the 
Pederzoli Hospital, in Peschiera del Garda (Verona-Italy). The PD patients fulfilled 
formal diagnostic criteria for PD according to the Unified Parkinson’s Disease Rating 
Scale (UPDRS; Fahn & Elton, 1987; Goetz et al., 2003); in this group the mean disease 
duration was of 5.5 years (range of onset 1–14 years, sd= 3.4) and the mean estimated 
motor sub score on the UPDRS was of 9.9 (range 3.5-2; sd= 4.5).  
PD Patients were asked to continue taking their medication at the required time on the 
day of testing session: nine patients received dopamine precursors (levodopa), two 
patients were receiving dopamine agonists, three received a monoamine oxidase 
inhibitor (MAOI) and five patients were taking a combination of levodopa and 
dopamine agonists.  PD patients and older subjects were matched for age, gender and 
education (see table 4.1). Participants gave signed informed consent after the purpose of 
the study and the protocol had been explained to them. 
 
Exclusion/Inclusion	   criteria. Inclusion criteria for this study were participants with 
normal or corrected to normal vision. Exclusion criteria applied for the recruitment of 
healthy participants were the presence of neurological disease (any medical conditions 
associated with a head injury, epilepsy, stroke), reported history of psychiatric disorder 
or neurological disease and use of psychiatric and neurological medications. 
Additionally, for adult, old and PD patients exclusion criterion was a Mini Mental State 
Examination (MMSE; Folstein et al., 1975) score under the cut-off (24).  
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TABLE	  4.1	  Means	  and	  standard	  deviations	  of	  the	  demographical	  characteristics	  of	  the	  
four	  groups.	  Tests	  refer	  to	  the	  match	  between	  old	  subjects	  and	  PD	  patients.	  
 
Notes: Variations on degrees of freedom (df) in t-test calculation are due to significant Levene test.  
 
 
Measures 	  
Neuropsychological	   assessment. Old participants and PD patients were invited to 
attend a neuropsychological assessment session. In detail, after the screening with 
MMSE (Folstein et al., 1975) that assessed the study eligibility, the following 
standardized tests were administered. Phonemic fluency test and Brown Peterson 
technique (10” and 30”) tasks were selected from the battery Esame Neuropsicologico 
Breve-2 (ENB2, Mondini et al., 2011), to evaluate respectively verbal production and 
response generation and short term memory in condition of interference. The Frontal 
Assessment Battery (FAB; Dubois et al., 2000; see also Apollonio et al., 2005) was also 
administered, to have a global index of EF. Testing materials are reported in Appendix. 
 
Experimental	   task. The experimental design of the new task employed in the present 
study is described in figure 4.1. The experiment ran with the E-Prime 2 software 
(Psychology Software Tools, Pittsburgh, PA) installed on a personal computer equipped 
with a 17” monitor. The general structure of the task was the following: two condition-
action biconditional rules (“if X occurs, then do Y; otherwise do Z”), independent and 
categorized with the A or B, were presented at the center of the screen. In these rules 
only one of three geometrical figures, a circle, a square or a triangle, was associated 
with a response key. Participants were asked to learn both rules and the duration of this 
learning phase was self regulated by every participants. 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	  Data collected in collaboration with Michele Burigo, Doris Pischedda and Paolo Cherubini	  
	   Young1	  
N=	  20	  
Adults	  
N=	  22	  
Old	  
N=	  20	  
PD	  patients	  
N=	  20	  
test	  	  
(df)	  
p-­‐
value	  
Age	  (years)	   23.5	  ±	  2.3	   61.7	  ±	  3.1	   71.9	  ±	  2.5	   69.3	  ±	  5.9	   t	  (25.4)=1.81	   ns	  
Gender	   7	  M	   13	  M	   11	  M	   12	  M	   x2(1)=.102	   ns	  
Education(years)	   15.9	  ±1.4	   7.4	  ±	  3.4	   6	  ±	  3	   7.1	  ±	  3.4	   t	  (38)=-­‐1.08	   ns	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When they declared to have learned the two rules, one of the two letters, A or B, were 
presented as cue, indicating which of the two rules become relevant for the task; 
participants were then asked to associate the current trial, a trigger stimulus represented 
by one of the three geometrical figures, with the appropriate response key. Participants 
responded using the left or the right button of an analogue computer mouse, labelled 
with the number 1 and 2 in a counterbalance way across participants.   
In detail, the trigger stimulus was classify as relevant if it matched the condition of the 
cued rule; critical if matched the condition of the uncued rule and neutral if it did not 
match the condition of any rule; In addition the two rules were classified as congruent 
or not: the congruence depended on the response suggested to the critical triggers by the 
two rules presented; during congruent trials the uncued rule suggested the appropriate 
response to the critical trigger while during incongruent trials the irrelevant rule 
suggested inappropriate response to the critical trigger. 
Six experimental conditions originated from a fully orthogonal 2x3 within-participants 
factorial design, which includes two congruence condition (congruent vs. incongruent 
trials) and three relevance conditions of the trigger figure (relevant, critical and neutral).  
As result of all possible combinations between congruence of trial (congruent or 
incongruent), key responses (key 1 or key 2), cues (A or B) and trigger figures (triangle, 
square, or circle) 144 trials in the experimental session were presented.  Trials in which 
the two rules had the same condition were omitted. The experimental session was 
structured in this way: after participants read self-paced instructions displayed on a 
computer, two blocks of practice trials were administered. In the first practice block 
participants were trained on how to interpret each task rule. Only one rule at a time was 
displayed, no cue was presented, and an accuracy feedback was given after each 
response. The practice block ended as soon as the participant provided five correct 
responses across the final six trials. In the second practice section, detailed instructions 
about the two-rules structures were described, explaining how to interpret the cue that 
follow the learning phase. Participants were explicitly told that only the cued rule 
should govern responses, while the uncued rule was irrelevant and must be ignored. 
After five practice trials, randomly selected from the 144 experimental trials, the 
experimental phase started.  
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                                          Congruent condition           OR         Incongruent condition 
  
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  	  	  	  	  	  A)	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	  	  	  	  	  	  	  	  	  	  	  	  B)	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2	  	  	  	  	  	  	  
	  	  A)	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	  	  	  	  	  	  	  	  B)	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	  
	  	  	  	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  -­‐B-­‐	  
	   	   	  OR	   OR	  
FIGURE	  4.1:	  the experimental design with examples of each type of trial and congruence conditions.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (Beep!)	  
	  
Display	  1:	  	  
Presentation	  of	  the	  Rules	  
	  
Istruction:	  Read	  each	  one	  as	  	  
“if	  you	  see	  [figure],	  
then	  press	  [numbered	  key];	  
	  otherwise,	  press	  [alternative	  	  
numbered	  key]”.	  	  
Display	  was	  self-­‐paced,	  
participants	  nodded	  when	  	  
they	  were	  confident	  that	  
they	  remembered	  the	  rules	  and	  wished	  	  
to	  proceed.	  Inter	  -­‐stimulus	  Interval	  [ISI]=0	  ms.	  
Display	  2:	  	  
Cue	  presentation	  
	  
Either	  an	  A	  or	  a	  B,	  
which	  was	  
counterbalanced	  across	  
trials.	  The	  letter	  
indicates	  which	  rule	  
applies	  to	  the	  following	  
trigger.	  The	  other	  rule	  
is	  irrelevant.	  In	  this	  
example,	  rule	  B	  must	  be	  
applied.Display	  time:	  
750	  ms.	  
ISI=0ms.	  
Display	  4:	  Feedback	  
	  
Inter-­‐trial	  blank	  	  
screen	  (350	  ms),	  
after	  which	  a	  new	  
trial	  	  
began.	  Acoustic	  
feedback	  	  
was	  provided	  	  
	  	  	  	  	  	  Relevant	  trial	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Critical	  trial	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Neutral	  trial	  	  
Display	  3:	  	  
Trigger	  figures	  	  
 
Participants	  must	  apply	  the	  
cued	  rule	  and	  produce	  the	  response	  
accordingly,	  by	  pressing	  either	  Key	  1	  or	  
Key	  2.	  In	  the	  critical	  trial,	  the	  trigger	  
figure	  matches	  the	  antecedent	  of	  the	  
uncued	  rule	  and	  might	  cause	  
interference	  (incongruent	  condition)	  or	  
facilitation	  (congruent	  condition)	  
effects.	  	  	  
Display	  time:	  until	  response	  or	  30s.	  	  
ISI=0	  ms.	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  Data	  analysis	  	  
Preliminary analyses of response times (RT) and accuracy rates were performed with 
the aim to evaluate group’s differences in terms of speed and accuracy. These raw data 
were submitted to a repeated measure ANOVA 2 (condition: congruent vs incongruent) 
x 3 (trigger: relevant, critical and neutral) x 4 (group: young, adults, old and PD 
patients). Participants’ RT and accuracies were also submitted to the normalization 
procedure (see figure 4.2), in order to calculate pure measure of facilitation and 
interference. Using this normalization procedure, which removes the effects of 
differences in terms of absolute speed and accuracy, it is possible to obtain conservative 
indices of facilitation and interference by the contrast of normalized critical vs. neutral 
trials. In this way, pure measures of the effect of the irrelevant rule on the response are 
obtained. Normalized accuracy rates and response times were submitted to different 
repeated measure analysis of variance (rANOVA), with the within subject factors 
condition (congruent vs incongruent) and trigger (critical vs neutral), and considering 
group (young, adults, old and PD patients) as between subject factor. 
 
Normalized	  RT	  Critical	  trigger:	  Mean	  RT	  critical	  trigger/	  Mean	  RT	  relevant	  trigger	  
Normalized	  RT	  Neutral	  trigger:	  Mean	  RT	  neutral	  trigger/	  Mean	  RT	  relevant	  trigger	  
	  
	  
Normalized	  accuracy	  Critical	  trigger:	  Accuracy	  critical	  trigger/	  Accuracy	  relevant	  trigger	  
Normalized	  accuracy	  Neutral	  trigger:	  Accuracy	  neutral	  trigger/	  Accuracy	  relevant	  trigger	  
	  
FACILITATION	  AND	  INTERFERENCE	  EFFECTS	  CALCULATION	  
	  
Facilitation	  
Δ	  RT	  =	  (Normalized	  RT	  congruent	  Critical	  trigger)	  –	  (Normalized	  RT	  congruent	  Neutral	  
trigger)	  
Δ	  Accuracy	  =	  (Normalized	  accuracy	  congruent	  Critical	  trigger)	  –	  	  (Normalized	  accuracy	  
congruent	  Neutral	  trigger)	  
	  
Interference	  
Δ	  RT=	  (Normalized	  RT	  incongruent	  Critical	  trigger)	  –	  	  (Normalized	  RT	  incongruent	  Neutral	  
trigger)	  
Δ	  Accuracy	  =	  (Normalized	  accuracy	  incongruent	  Critical	  trigger)	  –	  	  (Normalized	  accuracy	  
incongruent	  Neutral	  trigger)	  
	  
	  
Figure 4.2: normalization procedure for response times and accuracy rates 
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4.3	  Results	  
 
Neuropsychological	  assessment	  
Mean performances of old subjects and PD patients are reported in table 4.2.  Results of 
a between groups comparison revealed that, in spite of the absence of differences in the 
MMSE scores, PD patients had significant lower FAB total score and they had lower 
scores in BPT 10” and 30” tests. On the contrary, the mean number of words 
pronounced in the phonemic fluency test was not different between the two groups, 
indicating comparable response generation and verbal production.  
 
TABLE	   4.2	   Neuropsycological	   assessment.	  Mean	   scores	   and	   standard	   deviations	   of	  
old	  subjects	  and	  PD	  patients’	  performance.	  
	  
	   Old	  	  
	  N=20	  
PD	  patients	  	  
N=20	  
t	  test	  	  
(df)	  
p-­‐value	  
MMSE	  	   28.5	  ±	  1.05	   27.8	  ±	  1.5	   1.53	  (31)	   ns	  
FAB	  	   15.5	  ±	  1.83	   13.9	  ±	  2.4*	   2.21(38)	   .033	  
Phonemic	  fluency	   8.25	  ±	  2.4	   9.01	  ±	  4.1	   -­‐.71	  (30.3)	   ns	  
BPT	  10”	   6.6	  ±	  1.7	   5.1	  ±	  2.8*	   2.05	  (31.6)	   .047	  
BPT	  30”	   6.5	  ±	  1.8	   4.7	  ±	  2.8*	   2.43	  (33.1)	   .020	  
Notes: Variations on degrees of freedom (df) calculation are due to significant Levene test. MMSE: Mini-
Mental state examination; FAB: frontal assessment battery; BPT: Brown Peterson technique. In the 
phonemic fluency the score represents the mean number of words pronounced.  
 
 
Experimental	  task	  	  
Raw response times and accuracy rates at relevant, critical and neutral trial are reported 
in the table 4.3. In the same table are also reported facilitation and interference effects 
calculated following the normalization procedure (see figure 4.2).  
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TABLE	  4.3	  Raw	  response	  times	  and	  accuracy	  rates	   (mean	  and	  standard	  deviations).	  
Facilitation	  and	  interference	  measures	  are	  also	  provided.	  	  	  
 
Group	   Condition	   Response	  times	  
(ms)	  
ΔRT	  
(ms)	  
Accuracy	  
(%)	  
Δ	  Accuracy	  
(%)	  
	  
	  
	  
Young	  
	  
Congruent	  
Relevant:	  782.9	  ±	  229	  
Critical:	  1097.3	  ±	  276	  
Neutral:	  1210.3	  ±	  340	  
	  
Facilitation	  -­‐9	  
Relevant:	  91	  ±	  2	  
Critical:	  86	  ±	  3	  
Neutral:	  85	  ±	  4	  
	  
Facilitation	  +0,8	  
	  
	  
Incongruent	  
Relevant:	  745.1	  ±	  258	  
Critical:	  1057.1	  ±	  344	  
Neutral:	  974.4	  ±	  290	  
	  	  
Interference	  +2	  
Relevant:	  91	  ±	  3	  
Critical:	  84	  ±	  4	  
Neutral:	  92	  ±	  4	  
	  
Interference	  	  -­‐9	  
	  
	  
	  
Adult	  
	  
Congruent	  
Relevant:	  2083	  ±	  219	  
Critical:	  2467.7	  ±	  263	  
Neutral:	  2713.8	  ±	  324	  
	  
Facilitation	  -­‐10	  
Relevant:	  76	  ±	  3	  
Critical:	  72	  ±	  3	  
Neutral:	  70	  ±	  3	  
	  
Facilitation	  +0,5	  
	  
	  
Incongruent	  
Relevant	  1960.2	  ±	  246	  
Critical:	  2474.7	  ±	  328	  
Neutral:	  2357.1	  ±	  277	  
	  	  
Interference	  +	  8	  
Relevant:	  77	  ±	  3	  
Critical:	  63	  ±	  4	  
Neutral:	  74	  ±	  4	  
	  
Interference	  -­‐15*	  
	  
	  
	  
Old	  
	  
Congruent	  
Relevant:	  2859.4	  ±	  229	  
Critical:	  3622.7	  ±	  276	  
Neutral:	  4530.4	  ±	  340	  
	  
Facilitation	  -­‐53*	  
Relevant:	  72	  ±	  3	  
Critical:	  59	  ±	  3	  
Neutral:	  47	  ±	  4	  
	  
Facilitation	  +18*	  
	  
	  
Incongruent	  
Relevant:	  3005.1	  ±	  258	  
Critical:	  4223.4	  ±	  344	  
Neutral:	  3607.1	  ±	  290	  
	  	  
Interference	  +	  16	  
Relevant:	  69	  ±	  3	  
Critical:	  48	  ±	  4	  
Neutral:	  63	  ±	  4	  
	  
Interference	  -­‐21	  *	  
	  
	  
	  
Patients	  
	  
Congruent	  
Relevant:	  2322.5	  ±	  229	  
Critical:	  2743.7	  ±	  276	  
Neutral:	  3116.9	  ±	  340	  
	  
Facilitation	  -­‐17	  
Relevant:	  70	  ±	  3	  
Critical:	  62	  ±	  3	  
Neutral:	  52	  ±	  4	  
	  
Facilitation	  +10*	  
	  
	  
Incongruent	  
Relevant:	  2422.1	  ±	  258	  
Critical:	  2842.7	  ±	  344	  
Neutral:	  2977	  ±	  290	  
	  	  
Interference	  -­‐4	  
Relevant:	  62	  ±	  3	  
Critical:	  45	  ±	  4	  
Neutral:	  63	  ±	  4	  
	  
Interference	  -­‐26	  *	  
Notes: Δ = [(critical trigger/ relevant trigger) - (neutral trigger/ relevant trigger)]; * Significant 
difference refers to a p value <.05.  
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FIGURE 4.3: mean raw RT for every trigger figure presented. Panel A) congruent condition. 
Panel B) incongruent condition. * Significant difference refers to a p value <.05. Error bars 
represent standard errors. 	  
Response	  times	  
Raw	   values. Results of raw response times analysis yielded a main effect of group 
[F(3,78)=18.75 p=.001 np2 = .419], that indicated increasing RT from adult to old and 
patients group, comparing with the young participants, but non significant differences 
between PD patients, adult and old groups. The same analysis revealed a main effect of 
trigger [F(2,156)=34.04 p=.001 np2 = .30] and a significant interaction trigger*condition 
[F(2,156)=11.53 p=.001 np2 = .129], showing slower RT for neutral triggers, especially 
in congruent condition. The significant interaction trigger*condition*group 
[F(6,156)=3.23 p=.01 np2 = .11] showed that this modulation of neutral trigger responses 
by conditions is significant only in the old participants, who modulated also critical 
trigger responses depending on condition. Furthermore, post hoc comparisons indicated 
that only old participants showed a significant difference between critical and neutral 
trigger in both conditions, in terms of absolute values of response times (see figure 4.3). 
The analysis of normalised data, which permits the evaluation of facilitation and 
interference effects, was then conducted to confirm these results. 
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Normalized	   values. Results of the normalised response time analysis showed a 
significant but small effect of condition [F(1,78)=4.07 p=.047 np2 = .05] and a 
significant interaction trigger*condition [F(1,78)=13.12 p<.005 np2 = .14]. Post hoc 
comparisons indicated that if compared with the neutral trigger, critical triggers bring to 
a different response depending on the condition: in congruent conditions it manifests a 
significant facilitation effect (p<.01), while in incongruent conditions the direction is 
the opposite, close to an interference effect (p=.058). The triple interaction 
trigger*condition*group was not significant [F(3,78)=2.37 p=.07 np2 = .08]. 
To evaluate the significance of facilitation and interference effect a within group 
analysis was performed using Fisher test and applying a Bonferroni correction for 
multiple comparisons. Results indicated that the only significant effect is manifested by 
the old group, that showed a significant facilitation effect was significant (p<.005) but a 
non significant interference effect (p=.058). Young, adult and PD patients group did not 
show any significant effect in this response times analysis (see figure 4.4). 
 
 
 
 
 
FIGURE 4.4: facilitation and interference effects in the four groups. * Significant 
difference refers to a p value <.05. Error bars represent standard errors. 
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Accuracy	  
Raw	   values. Results of raw accuracy rates analysis showed a main effect of group 
[F(3,78)= 28.7 p=.001 np2 = .52], that indicated decreasing accuracy rates from adult to 
old and patients group, comparing with the young participants, but non significant 
differences between PD patients and old  group. As the previous one on raw RT, this 
analysis revealed a main effect of trigger [F(2,156)=38.92 p=.001 np2 = .33], indicating 
higher accuracy for relevant triggers and lower for critical ones; the significant 
interaction trigger*condition [F(2,156)=36.72 p=.001 np2 = .32] showed that accuracy 
on critical and neutral trigger is also significantly modulated by condition, with 
congruent conditions that increase the accuracy of critical response, reducing those of 
neutral ones (see figure 4.5).  
 
 
 
FIGURE 4.5: raw accuracy rates for every trigger figure presented.  Panel A: congruent 
condition; Panel B: incongruent condition. * Significant difference refers to a p value <.05. 
Error bars represent standard errors. 
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The significant interaction trigger*condition*group [F(6,156)=2.59 p=.05 np2 = .09] 
showed that the response at critical and neutral triggers are modulated by conditions not 
in all groups: in fact, while in congruent conditions only old  showed a significant 
difference between critical and neutral responses, in incongruent conditions every group, 
except young, manifested different accuracy patterns in critical and neutral triggers (see 
figure 11). Finally, the condition*group significant interaction [F(3,78)=2.94 p=.05 np2 
= .099] revealed as PD patients were less accurate in the incongruent condition, respect 
to their performance in the congruent one (see figure 4.6). 
 
 
 
 
FIGURE 4.6: accuracy rates measured as function of the congruence of the condition. 
*Significant difference refers to a p value <.05. Error bars represent standard errors. 
 
 
 
Normalized	  values. The rANOVA on normalized accuracy rates yielded a main effect 
of group [F(3,78)= 4.05 p<.05 np2 = .135] and a main effect of trigger [F(1,78)= 11.29 
p<.005 np2 = .126], with higher normalized accuracy for neutral triggers (93%) respect 
to critical ones (86%).  
The same analysis revealed also significant interactions: trigger*condition [F(1,78)= 
48.6 p<.001 np2 = .384] and trigger*condition*group [F(3,78)= 3.13 p<.05 np2 = .108]. 
Using Fisher test to evaluate the significance of facilitation and interference effects, it 
was shown that while young participant did not show any effect and adults showed only 
interference, old and PD patients showed both facilitation and interference significant 
effects (see figure 4.7).  
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FIGURE 4.7: facilitation and interference effects in the four group. Only old and PD 
patients showed significant effects. * Significant difference refers to a p value <.05. Error 
bars represent standard errors. 
 
4.4	  Discussion	  and	  conclusion	  
 
In the present study, a new WM task was applied in young, adults and old healthy 
people, and in a group of medicated PD patients as well. The first aim of the study was 
to explore top down components of WM: executive attention and inhibition. In detail 
the task employed in this study has been designed with the objective of exploring the 
focusing of attention on WM representations, referring to studies that suggested a cross 
modal nature of selective attention (Chun et al., 2011; Cherubini et al., 2007; Cherubini 
et al., 2006). Inspired by a classical Stroop task (Stroop, 1935), in which both relevant 
and irrelevant stimulus features are simultaneously present and combined in a congruent 
or incongruent manner, in our task two condition-action biconditional rules (“if X 
occurs, then do Y; otherwise do Z”), relevant and irrelevant, were designed as 
congruent or incongruent, with the aim of observing possible facilitation and 
interference effects in WM, as it happens with conflicting perceptual information (e.g., 
Stroop effect). To our knowledge this is the first study that explores the critical ability 
of focusing on a relevant task rule while ignoring or inhibiting irrelevant ones in 
circumstances in which the rules have just been learned and are transiently encoded in 
WM.  
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Second but complementary aim was to exploration of these capacity, executive attention 
and inhibition in WM, during the lifespan, following the current need to define the 
nature of the WM decline during ageing. Final aim of the present study was to study the 
performance of medicated PD patients in this new task, with the objective of exploring 
top down components of WM in a condition of possible dopaminergic “dysregulation”. 
Our first prediction was to find increasing facilitation and interference effects during the 
lifespan, basing on findings about age related vulnerability to interference, and declines 
in WM (Reuter-Lorenz & Sylvester, 2005). On the other hand, prediction about PD 
patients’ performance was more difficult to define. On the basis of neuroimaging 
studies that suggest a primary role of the dopaminergic frontal-basal connection in the 
filtering of irrelevant information in WM (Baier et al., 2010; McNab & Klingberg, 
2007; Vogel et al., 2005; Frank et al., 2001; Goldman-Rakic, 1996) a worse 
performance of PD patients, compared to healthy controls, was expected, in a task in 
which selection and inhibition capacities are required. On the contrary, contrasting 
results about medicated PD patients’ performance in WM tasks (Moustafa et al., 2008) 
did not permit a specific prediction and suggested a cautious exploration of their 
performance.  
Our results showed that facilitation and interference effects, similar to those obtained in 
a Stroop task, can be obtained also in reasoning task, where symbolic representations 
have to be managed and maintained in WM.  Irrelevant information, transiently encoded 
in WM, can affect the response guided by the relevant information. Moreover, the effect 
of irrelevant information is modulated by its relation with the relevant one, generating 
facilitation if there is a congruence, and inducing interference if there is incongruence 
between the responses suggested. These effects are manifested in the latency but also in 
the accuracy of the responses, where the lack of inhibition of the irrelevant information 
is manifested with the “capture errors” (Rasmussen, 1982; Reason, 1990). Capture 
errors, generally described in perceptual domain, in this case do not originate from 
having omitted a relevant rule but from the inability to inhibit an irrelevant rule, and for 
this reason represents a valid measure of inhibition capacity. In our cross-sectional 
analysis, significant interference and facilitation effects emerged in adult and old 
subjects, indicating that inhibition capacity is not perfectly efficient as it is in younger 
people. Latency data showed that only old subjects manifest significant facilitation 
effects; on the other hand accuracy rates showed significant interference effects in adult 
subjects, and both facilitation and interference in old participants.  
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This different manifestation of facilitation and interference effects could also support 
the hypothesis of independence between these two effects (Lindsay & Jacoby, 1994) 
and, moreover, of different age-related changes in their manifestation. Taken together, 
results of the application of this new task in healthy people demonstrated that top down 
components of WM, executive attention and inhibition, seem to follow the same 
mechanism employed in the attention domain, with the same benefits and costs. 
Furthermore our task highlighted important ageing effects on these WM components, 
showing that an age-related decline of inhibition capacity can affect the management of 
symbolic information in WM.  
Results from the application of this task in PD patients showed instead a complex 
pattern of performance. In the present study we tested a group of PD patients under 
dopaminergic treatment and we considered the group of old healthy subjects as a 
matched condition. Both groups were evaluated with standardized neuropsychological 
tests to exclude general cognitive decline and to compare performance in EF tests and in 
a demanding short memory test. Results showed that our sample of PD patients, even in 
absence of generalized cognitive decline, had specific cognitive deficits on EF, like 
inhibition and abstraction. Furthermore, PD patients manifested a poorer capacity to 
remember verbal material in conditions of interference. Despite that, results from the 
experimental task revealed that patients were not slower or less accurate than the control 
group. From the analysis of normalized values it was possible to observe a complex 
pattern: while PD patients showed significant facilitation and interference effects 
measured on accuracy rates, like the control group, they did not show any significant 
effect measured on RT. This lack of effects on RT, which could represents a preserved 
control of motor response, is quite surprising, especially considering the absence of 
difference on RT between PD patients and old subjects. Non-demented PD patients 
under dopaminergic treatment and with EF deficits seemed to show a better 
performance, in terms of normalised RT, compared to healthy control subjects without 
EF deficits. The absence of RT effects in PD patients opens to several interpretations. 
On one side, the greater task sensitivity to detect facilitation and interference effects on 
accuracy rates should invite us to a cautious interpretation of latency data. On the 
opposite side, because of the normalization procedure, every value can be viewed as a 
pure measure of interference or facilitation independently from the group differences in 
average performance.  
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Following this assumption, considering latency data we could conclude that our 
medicated PD patients showed a better performance and seemed to be less sensitive, in 
terms of response times, to irrelevant information stored in WM. This is a surprising but 
plausible conclusion, in the light of the contrasting evidence about the role of 
dopaminergic medication on different aspects of WM tasks (see Moustafa et al., 2008). 
However, the same PD patients showed significant facilitation and interference effects 
in the accuracy rates and, unlike their control group, showed different accuracy rates 
depending on the congruence of the two information stored.  
Performing an unplanned “a posteriori” analysis with the aim of understanding this 
result, we correlated these raw accuracy rates with scores obtained from 
neuropsychological assessment. What we found is an interesting correlation between 
FAB (Dubois et al., 2000; Apollonio et al., 2005) total score and the accuracy rates of 
the incongruent condition (Spearman rho = .35; p<.05). Assuming that most part of the 
FAB score is made up by items that explore inhibitory control and sensitivity to 
interference, the result of this additional correlation analysis adds information and could 
help us in reaching an overall conclusion.  
The emergence of significant facilitation and interference effects on accuracy rates, in 
ageing and PD patients, confirms the assumption that key variable of this WM task is 
represented by the induction of the so called capture errors (Reason, 1990; Rasmussen, 
1982). This type of errors represents a preferable index to evaluate WM executive 
components in this task. Capture errors permitted to highlight age related declines in top 
down components of WM, like executive attention and inhibition capacity but also 
allowed to underline an important feature of PD patients’ performance. PD patients 
performed worse when there was conflicting information to maintain and to manage in 
WM, suggesting a different WM storage ability in this clinical sample. This finding 
could support the hypothesis that BG provide a gate on WM updating, and it is coherent 
with recent neuroimaging findings that showed as the degree of BG activity is 
predictive of whether or not irrelevant information is unnecessarily stored in WM 
(McNab &Klinberg, 2008). Nevertheless, latency data of PD patients suggest further 
exploration. Due to our experimental design, in which patients were tested only in the 
“on” phase, we can only suppose that differences in latency were due to an 
enhancement of motor function by the dopaminergic medication.  
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Given the increasing literature about the role of dopaminergic treatment in WM 
performance (for a review see Moustafa et al., 2008; see also Lewis, et al. 2005; Costa 
et al., 2003; Marini et al., 2003; Owen et al., 1995; Lange et al., 1992; Cooper et al., 
1991; Poewe et al., 1991), we can however hypothesize a possible future direction, i.e. 
the consideration of dopaminergic medication role in this task, with the aim of 
exploring the relation between dopamine and top down components of WM.	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CHAPTER	  V	  -­‐	  SECOND	  STUDY	  
EXECUTIVE	  FUNCTIONS	  AND	  FEEDBACK	  PROCESSING:	  MOTIVATIONAL	  
INFLUENCES	  ON	  COGNITIVE	  CONTROL	  IN	  AGEING	  AND	  IN	  PARKINSON’S	  
DISEASE	  
	  
5.1	  Introduction	  	  
The human ability to focus attention on relevant information and to neglect, at the same 
time, the irrelevant one, is a crucial issue in cognitive psychology. This ability is called 
cognitive control and is thought to origin from a dedicated cognitive mechanism that 
coordinates goal-driven behaviour (Norman & Shallice, 1986; Shiffrin & Schneider, 
1977; Posner & Snyder, 1975; Broadbent, 1958).  Cognitive control function is 
considered a high level process, which is commonly included in executive functions 
(EF), due also to its association with prefrontal cortex (PFC) activity (for a review see 
Miller, 2000).  One of the functions of cognitive control is to adapt the cognitive system 
to different environmental situations (Kahneman, 1973) and this adaptation is usually 
driven by the detection of cognitive conflict (Botvinick et al., 2001), i.e. situation of 
interference between relevant and distracting stimuli. In cognitive psychology different 
conflict tasks were designed to study cognitive control: a common feature of these tasks 
is the presence of irrelevant information that slows down the processing of relevant 
information. In the Simon task (see box 1) left or right responses are associated with 
non-spatial stimulus features, whereas the stimulus is presented either on the left or the 
right side. Responses are faster and more accurate when stimulus and response location 
correspond, i.e. corresponding (C) trials, than when they do not correspond, i.e. non-
corresponding (NC) trials. The difference between responses to C and NC trials is 
called Simon effect (Simon & Small, 1969).  Despite this traditional structure of 
conflict task, it is generally recognized that cognitive control is involved not only in 
situation of cognitive interference and conflict, but it also “invoked” in emotional 
situations as danger (Norman & Shallice, 1986; Baddeley, 1972). Neuroimaging studies 
support this assumption: recent findings report that while the dorsolateral prefrontal 
cortex is a crucial region for the employment of cognitive control (Miller & Cohen, 
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2001) the anterior cingulate cortex is involved in signaling the need for the allocation of 
extra cognitive control (Botvinick et al., 2001). In detail, the anterior cingulate cortex is 
involved in the monitoring of cognitive conflict (Kim et al., 2013; Botvinick et al., 
2001- 2004), but also responds to negative emotions, such as pain and negative 
feedbacks (Fomberstein et al., 2013; Santesso et al., 2012; Schakman et al., 2011; 
Botvinik, 2007). 
 
Box	  1:	  Simon	  task	  and	  Simon	  effect	  
	  
In	  cognitive	  psychology,	  different	  laboratory	  tasks	  were	  developed	  with	  the	  aim	  to	  measure	  
cognitive	  control	  capacity	  in	  humans.	  Common	  feature	  of	  these	  tasks	  is	  the	  induction	  of	  
conflict	  between	  the	  processing	  of	  relevant	  and	  irrelevant	  information.	  In	  the	  Simon	  task	  
(Simon	  &	  Rudell,	  1967;	  Simon	  &	  Small,	  1969)	  conflict	  is	  created	  by	  the	  automatic	  tendency	  to	  
respond	  to	  the	  stimulus	  location,	  irrelevant	  dimension	  of	  stimulus	  target	  that	  interferes	  with	  
the	  response	  to	  relevant	  information.	  The	  correspondence	  between	  stimulus	  location	  and	  
response	  button	  creates	  two	  different	  conditions:	  corresponding	  and	  not	  corresponding.	  
	  
	  
Non-­‐corresponding	  trials	  (right	  picture)	  make	  people	  slower	  and	  less	  accurate	  in	  comparison	  
to	  corresponding	  conditions	  (left	  picture).	  The	  significant	  difference	  between	  the	  
performances	  in	  these	  two	  conditions	  is	  named	  “Simon	  Effect”	  (Simon,	  1969).	  
	  
Moreover,	  sequential	  analyses	  have	  provided	  evidence	  for	  trial-­‐to-­‐trial	  adjustments:	  the	  
Simon	  effect	  is	  	  	  function	  of	  stimulus–response	  correspondence	  in	  both	  the	  current	  trial	  and	  
the	  previous	  trial.	  In	  detail	  the	  Simon	  effect	  is	  less	  pronounced,	  or	  even	  absent,	  if	  the	  
previous	  trial	  is	  non-­‐corresponding.	  	  
This	  phenomenon	  is	  known	  as	  “conflict	  adaptation	  effect”	  (Gratton	  et	  al.,	  1992).	  
	  
CORRESPONDING	   NON	  CORRESPONDING	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On the basis of this assumption, many variants of the classical conflict tasks were 
proposed. A first variant introduced emotional stimuli creating “emotional conflict” 
situations with the aim of exploring the interaction between emotion processing and 
conflict resolution (Padmala et al., 2011; Egner et al., 2008; Etkin et al., 2006). Other 
variants, instead, introduced additional emotional variables during the execution of 
classical tasks, to evaluate if these variables might influence different aspects of conflict 
processing (Xue et al., 2013; Braem et al., 2012; van Steenbergen et al., 2012; Chiew et 
al., 2011; Sturmer et al., 2011; Kanske & Kotz, 2011a-b; 2010; Krebs et al., 2010). 
What links these studies is the objective of exploring the role of an emotional 
manipulation on cognitive control, trying to explore the interaction between emotional 
stimuli, positive or negative, and the recruitment of attentional resources. Despite an 
increasing interest in this research field, most of these studies have explored the effect 
of emotional stimuli in conflict tasks, neglecting the potential role of motivation. A 
consequent result is that the interaction between cognitive-control mechanisms and 
motivational variables is still not well understood (Braem, 2013). For these reasons we 
decided to investigate if, and how, different motivational contexts can modulate 
cognitive control. In detail, we created a new task in which two different performance 
contingent feedbacks were introduced as motivational incentives in a conflict task, with 
the goal to explore the role of these incentives in cognitive control. This new task was 
designed introducing performance-related rewards and punishments in a Simon task, to 
promote fast and accurate responses. 
First aim of this research concerned investigating the interaction between motivation 
and cognitive control, exploring in detail this phenomenon using a specified analysis 
approach, i.e. the diffusion model analysis (Ratcliff, 1978). Our objective was to 
explore if, and how, motivational aspect can influence the management of cognitive 
resources, from perceptual to decisional aspects.  
The second aim of this study was to investigate if, and how, the interaction between 
motivation and cognitive control changes during ageing. This second aim was 
motivated by shared knowledge about age-related decline of EF (see chapter II) and, 
moreover, was inspired by recent findings about age-related deficits in feedback 
processing and reward based-learning (Eppinger et al., 2011; Mell et al., 2009-2005; 
Dreher et al., 2008).  
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Finally, this new experimental paradigm was built also to investigate if, and how, the 
feedback processing deficits reported by medicated Parkinson’s disease (PD) patients 
(Kapogiannis et al., 2011; Bodi et al., 2009; Kobayakawa et al., 2010; Frank et al., 
2007-2004) can affect the interaction between motivation and cognitive control.  
The choice to study this phenomenon in ageing and in PD patients was motivated by at 
least two reasons. First of all, the mentioned knowledge about neural mechanisms 
involved in the interaction between affect, i.e. motivational or emotional factors, and 
cognitive control. The neural network that supervises the interaction between affect and 
cognitive control is mediated in fact also by dopaminergic activity. Given its critical 
role in reward processing and in motivational control (for reviews see Bromberg-Martin 
et al., 2010; Schultz, 1997) it has been proposed that dopamine mediates the interface 
between motivational and cognitive control (Aarts et al, 2010).  
In an overall view, if the anterior cingulate cortex and the dorsolateral prefrontal 
cortex may be involved in the detection and evaluation of cognitive demands and in 
the implementation of the cognitive control needed, the dopamine reward systems 
may play an important modulatory function in the regulation of this interaction.  
Exploring healthy ageing and PD patients under medication, in this study we want to 
explore the interaction between motivation and cognitive control in two conditions in 
which the dopaminergic system go through significant changes: a decline in ageing, and 
dysfunction in PD patients under medication. 
Lastly, proposing our task to healthy elderly and to medicated PD patients we will have 
important clinical information. Our paradigm was built to be also similar to those 
employed in cognitive rehabilitation settings. Cognitive rehabilitation programs, in fact, 
are based on the use of cognitive tasks in which the use of feedback is often 
recommended for the enhancement of motivation and for the improvement of the 
performance (Cicerone et al., 2011; Cappa et al., 2005). With our investigation we also 
want to explore the feasibility to use this kind of rehabilitation procedure in PD patients, 
a clinical condition in which general EF deficits (for a review see Dirnberger & Marjan, 
2013; Kudlicka et al., 2011) and specific feedback-processing deficits (Kapogiannis et 
al., 2011; Bodi et al., 2009; Frank et al., 2007-2004) may compromise their 
rehabilitation itself.  
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5.2	  Method	  	  
Participants	  
Fifty-seven participants were recruited for this study: twenty-seven young subjects (8 
male, age range= 20-35 years, mean= 24.7, sd=3.4), fifteen old subjects (4 male; age 
range= 48-81 years; mean= 68.1 sd=9.6) and fifteen PD patients (6 male; age range= 
49-85 years; mean= 71.8, sd=8.7) participated in the experiment after giving written 
informed consent. Young participants were recruited at the University of Padova, while 
both PD patients and old participants were recruited in the Rehabilitation division of the 
Hospital of Suzzara (Mantova-Italy). The PD patients fulfilled formal diagnostic criteria 
for PD according to the Unified Parkinson’s Disease Rating Scale (UPDRS; Fahn & 
Elton, 1987; Goetz et al., 2003), had a mean disease duration of 5.1 years (range of 
onset 2–13 years, sd= 3.8) and a mean estimated motor sub score of 22.13 (range 8-39, 
sd=10.2) on the UPDRS. Patients were asked to continue taking their medication at the 
required time on the day of testing, and testing sessions, which comprised cognitive 
assessment and experimental task. Six patients received dopamine precursors 
(levodopa), four patients were receiving dopamine agonists, three received a 
monoamine oxidase inhibitor (MAOI), and two patients were taking a combination of 
levodopa and dopamine agonists. Old participants and PD patients groups were matched 
for age, gender and education (table 5.1). 
 
TABLE	  5.1	  Means	   and	   standard	  deviations	   for	   demographical	   characteristics	   of	   the	  
tested	  samples;	  tests	  concern	  the	  comparison	  between	  old	  subjects	  and	  PD	  patients.	  
	  
 
 
 
	   Young	  
N=27	  
Old	  
N=	  15	  
PD	  patients	  
N=	  15	  
Test	  
(df)	  
p-­‐value	  
Age	  (years)	   24.7	  ± 3.4	   68.1	  ± 9.6	   71.8	  ± 8.7	   t	  (28)=-­‐1.07	   ns	  
Gender	   8	  M	   4	  M	   6	  M	   x2(1)=.60	   ns	  
Education	  (years)	   17.1	  ± 1.3	   8.1	  ± 3.5	   8.4	  ± 3.04	   t	  (28)=.223	   ns	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Exclusion/Inclusion	   criteria. Inclusion criteria for this study were participants with 
normal or corrected to normal vision. Exclusion criteria applied for the recruitment of 
young and old healthy participants were the presence of neurological disease (any 
medical conditions associated with a head injury, epilepsy, stroke), reported history of 
psychiatric disorder or neurological disease and use of psychiatric and neurological 
medications. Additionally, for both PD patients and old subjects exclusion criterion was 
a Mini Mental State Examination (MMSE; Folstein et al., 1975) score under the cut-off 
(24).  
 
Measures	  
Motivational	   Simon	  Task. The experimental design of the new task employed in the 
present study is described in figure 5.1. The experiment ran with the E-Prime 2 software 
(Psychology Software Tools, Pittsburgh, PA) installed on a personal computer equipped 
with a 17” monitor. The structure of the experimental task respected a traditional Simon 
task: stimuli consisted of circles and squares, presented randomly to the right or left of a 
central fixation point, displayed with two possible colours, red or green, against a white 
background. Participants responded to the colour of the stimuli by pressing one of two 
horizontally aligned response buttons on a keyboard (A for green and L for red figures), 
using their left and right index fingers. Each trial started with the presentation of a 
central fixation cross for a random duration (from 200 to 500 ms), followed by the 
stimulus, presented for 250 ms. The session started with a practice block of 40 trials and 
with a following training block of 120 trials. After these two initial blocks in which no 
feedbacks were delivered, reward and punishment blocks followed, composed of 224 
trials each, with one break after 123 trials. The presence of a short practice block has 
been designed to introduce the task before the recording of mean reaction times (RT) 
planned in the training block: the mean RT were calculated for C and NC trials, for the 
left and right responses separately. On the basis of the four means and standard 
deviations, for each participant four separate algorithms, for C and NC trials and each 
response, were calculated to identify the fastest responses that should be rewarded in the 
reward block [RT < mean RT of the training block – (0.75*sd)], and the slowest 
responses that have to be punished in the punishment block [RT > mean RT training 
block + (0.75*sd)].  
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With the use of these algorithms, in the reward block fast correct responses received a 
virtual bonus (+0.15 €), while in the punishment condition slow correct responses were 
penalized (-0.15 €). In both conditions, an acoustic feedback was given for errors; 
however, in the reward condition errors were not penalized, whereas in the punishment 
condition errors were punished like the slow responses (-0,15 €). After each feedback, 
the updated collected budget appeared at the bottom of the screen; at the end of 
experiment each participant had the information about their total virtual budget, as 
amount of total win and total loss. The order of reward and punishment blocks was 
counterbalanced across participants. 
of E 
 
Neuropsychological	   assessment. Both old healthy subjects and PD patients were 
invited to attend a neuropsychological assessment session, after the initial screening 
with the MMSE. This session consisted of a short battery of standardised 
neuropsychological EF tests, and took no longer than one hour to complete.  
	  
Stimulus	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
Feedback	  
	  
Blank	  
	  +	  	  
	  	  	  	  	  Fixation	  
	  
250	  ms	  
200	  –	  500	  ms	  
1000	  ms	  
2000	  ms	  
	  	  VINCI	  0,15	  €	  !	  
 Budget	  totale	  +	  9	  €	   	  	  PERDI	  0,15	  €	  !	   Budget	  totale	  -­‐7	  €	   
	  +	  	  
	   REWARD	  BLOCK	   PUNISHMENT	  BLOCK	  
FIGURE 5.1: schematic depiction of the motivational Simon task.  
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In detail, phonemic fluency test and Trial Making Test A and B were selected from the 
battery Esame Neuropsicologico Breve-2 (ENB2, Mondini et al., 2011), to assess 
respectively set- switching, inhibition and response generation. The Frontal Assessment 
Battery (FAB; Dubois et al., 2000; see also Apollonio et al., 2005) was also 
administered, to have a global index of EF. Testing material is reported in Appendix. 
 
Data	  analysis	  
Mean correct RT and accuracy rates were calculated in every group separately for each 
experimental block, reward and punishment. RT and accuracy data from the two blocks 
were also submitted to a diffusion model analysis (e.g., Ratcliff, 1978; Voss & Voss, 
2008-2007; Spaniol et al., 2006) to obtain four parameters of interest (see box 2). This 
method optimizes the fit between empirical and predicted cumulative RT distributions 
using the Kolmogorov-Smirnov (KS) test statistic. We allowed t0, z, v and a parameters 
to vary with each of the two conditions (C and NC trials) and we estimated separate 
diffusion models for reward and punishment blocks, for each participant of the three 
groups. Mean correct RT, accuracy rates and each parameter of the diffusion model 
were separately analyzed with a 2x2x3 mixed ANOVA, including the within subject 
factors block (reward vs punishment) and correspondence (corresponding vs non 
corresponding), and the between subject factor group (young, old and patients). Post-
hoc analyses were performed using Fisher test and applying Bonferroni correction for 
multiple comparisons.  
Diffusion	  model	  analysis	  
Model	  fit. We performed tests of fit separately for each diffusion model (i.e. for each 
participant and for each experimental block, resulting in a total of 114 models).  As 
index of model fit, the fast dm method (Voss & Voss, 2008-2007) calculated a KS test 
for each model, where a significant result (p< .05) signalled model misfit. In this study 
the KS tests revealed significant result only for one young participant; therefore, the 
results presented here consider 26 young participants, 15 old and 15 PD patients.  
Model	   parameters. Like raw RT and accuracy rates, every model parameter was 
analysed with a mixed ANOVA that included the within subject factors correspondence 
(C and NC) and block (reward and punishment), and the between subject factor group 
(young, old and PD patients).  
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Box	  2:	  Diffusion	  model	  
	  
During	   two-­‐choice	   decisions,	   information	   accumulates	   until	   a	   response	   boundary	   is	   reached	   and	   the	  
motor	   response	   is	   initiated.	   Assuming	   that,	   the	   diffusion	   model	   (Ratcliff,	   1978)	   decomposes	   the	  
performance	  into	  extra-­‐decisional	  processes,	  perceptual	  and	  motor,	  and	  decisional	  processes.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Graphical	  illustration	  of	  diffusion	  process	  in	  a	  two	  choices	  decision	  tasks	  (from	  Voss	  et	  al.,	  2004).	  
	  
Decisional	  processes	  	  
The	   model	   parameter	   a,	   known	   as	   response	   boundary,	   captures	   the	   distance	   between	   response	  
thresholds	  and	  is	  interpreted	  as	  a	  measure	  of	  conservatism.	  In	  detail,	  response	  boundary	  is	  a	  measure	  of	  
response	   caution	  or	   speed-­‐accuracy	   trade-­‐off	   (i.e.,	   the	  distance	  between	  decision	   boundaries).	  With	   a	  
larger	  response	  boundary,	  it	  takes	  longer	  for	  the	  decision	  process	  to	  reach	  its	  threshold,	  which	  decreases	  
the	  probability	  of	  an	  erroneous	  response	  (Merkt	  et	  al.,	  2013).	  	  
Second	  decisional	  parameter	  is	  the	  represented	  by	  the	  starting	  point	  (z),	  parameter	  that	  can	  map	  a	  priori	  
biases	   in	   the	   decision	   thresholds.	   Since	   z	   parameter	   can	   only	   be	   interpreted	   in	   its	   relation	   to	   a	  
parameter,	  it	  is	  preferable	  to	  report	  the	  relative	  starting	  point	  (zr	  	  =	  z	  /a),	  because	  if	  z	  differs	  from	  a/	  2	  
(i.e.,	  zr	  	  	  ≠	  0.5),	  different	  amounts	  of	  information	  are	  required	  before	  deciding	  on	  option	  A	  or	  B	  (Voss	  et	  
al.,	  2013).	  
Extra-­‐decisional	  processes	  	  
The	  model	  parameters	  v,	  the	  drift	  rate,	  indicates	  the	  relative	  amount	  of	  information	  per	  time	  unit	  that	  is	  
needed;	   it	   can	  be	   interpreted	   as	   a	  measure	  of	   perceptual	   sensitivity	   in	   a	   between-­‐person	   comparison	  
while	  in	  a	  between-­‐condition	  comparison	  is	  a	  measure	  of	  task	  difficulty	  (Voss	  et	  al.,	  2004).	  	  
The	  last	  parameter,	  t0,	  is	  defined	  as	  a	  measure	  of	  non	  decisional	  time,	  which	  consists	  of	  both	  motor	  and	  
encoding	  processes	  that	  precede	  the	  decisional	  phase.	  This	  parameter	  value	  indicates	  the	  duration	  of	  all	  
extra-­‐decisional	  processes	  (Voss	  et	  al.,	  2004).	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5.3 	  	  Results	  
	  
Neuropsychological	  assessment	  
The neuropsychological data collected in old subjects and PD patients are reported in 
table 5.2. Even if, according to the exclusion criteria, every participant of both groups 
had a score over the cut-off (24), PD patients had a significantly lower mean score on 
MMSE than the control group. At a further examination of EF, PD patients showed 
lower scores in every neuropsychological test for EF. A lower number of words 
pronounced in the phonemic fluency test indicates a poorer response generation, while a 
greater difference between Trial making test A and B indicated declined set-switching 
ability. Finally, a lower performance on both the version of BPT suggested a declined 
ability to remember verbal material in condition of interference. Taken together these 
results indicate that our sample of PD patients had an overall compromised EF system, 
comparing with a control group matched for age, gender and education.  
 
TABLE	   5.2	   Neuropsycological	   assessment.	  Mean	   scores	   and	   standard	   deviations	   of	  
old	  subjects	  and	  PD	  patients’	  performance.	  
	  
	  
	  
Old	  
N=15	  
PD	  patients	  
N=15	  
t	  test	  
(df)	  
p-­‐value	  
	  MMSE	  	   28.9	  ±	  1.4	   27.06	  ±	  2.2	   3.17	  (23.6)	   .004	  
Frontal	  Assessment	  Battery	   16.9	  ±	  1.3	   12.1	  ±	  3.1	   5.46	  (18.8)	   .000	  
Phonemic	  fluency	   9.9	  ±	  3.2	   7.4	  ±	  2.4	   2.45	  (28)	   .021	  
Trial	  Making	  test	  B-­‐A	   108.9	  ±	  64.1	   195.7	  ±	  132.3	   -­‐2.15	  (16)	   .033	  
Brown	  Peterson	  task	  10”	   6.73	  ±	  1.9	   4.53	  ±	  2.4	   2.8	  (29)	   .009	  
Brown	  Peterson	  task	  30”	   7.1	  ±	  1.7	   3.9	  ±	  1.9	   4.87	  (29)	   .000	  
MMSE: Mini-Mental state examination; FAB: frontal assessment battery; BPT: Brown Peterson 
technique. In the phonemic fluency the score represents the mean number of words pronounced. Notes: in 
the TMT B-A scoring (TMT B execution time - TMT B execution time) 13 patients are considered because 
two patients were not able to do the B section of the test. In the phonemic fluency the score represents the 
mean number of words pronounced. Variations on df (degree of freedom) calculation are due to 
significant Levene test.  
 
 
 
 
	   69	  
Motivational	  Simon	  Task	  
Performances of the three groups at the experimental tasks were reported in table 5.3: 
means and standard deviations for correct RT, accuracy rates and relative Simon effects, 
for each group and each experimental condition, were calculated.  
 
TABLE	  5.3	  Means	  and	  standard	  deviations	  of	  correct	  RT	  and	  accuracy	  rates,	  with	  
relative	  Simon	  effects.	  	  
 
Group Block Correspondence Mean  
RT  
(ms) 
Simon 
effect  
 
Mean 
accuracy 
(%) 
Simon 
effect 
Young Reward C 324.1 ±	  18.6 34.6 92 ±	  5 -10 
NC 358.7 ±	  17.8 82 ±	  11 
Punishment C 342.7 ±	  19.7 26.1 95 ±	  3 -4 
NC 368.8 ±	  19.8 91 ±	  4 
Old Reward C 483.3 ±	  24.2 62.3 96 ±	  2 -10 
NC 545.6 ±	  23.9 86 ±	  7 
Punishment C 478.4 ±	  26.5 51.9 96 ±	  3 -7 
NC 530.3 ±	  26.6 89 ±	  6 
PD 
Patients 
Reward C 628.6 ±	  24.2 65.7 91 ±	  7 -5 
NC 694.3 ±	  23.9 86 ±	  10 
Punishment C 640.9 ±	  26.5 64.02 92 ±	  9 -6 
NC 704.9 ±	  26.5 86 ±	  12 
Notes: C: corresponding trial; NC: non-corresponding trial. Simon effect: (NC – C).  
 
 
Reaction	   times. The rANOVA for correct RT yielded a main effect of 
correspondence [F(1,54)=258.45 p<.001 np2 = .827], confirming the presence of an 
overall Simon effect. The main effect of group [F(2,54)=55.44 p<.001 np2 = .67] 
indicated a significant slowing of RT going from young to old and PD patients. The 
significant group*correspondence interaction [F(2,54)=13.08; p<.001 np2 = .32; see 
figure 15a] was explored with a post hoc analysis on Simon effect values. Results of 
this additional analysis revealed that young participants showed a smaller overall Simon 
effect, respect to older and patients group; no significant differences were found 
between old and patients (figure 5.2). The interaction between block and 
correspondence resulted as not significant [F(2,54)=3.8 p=.056 np2 = .06].  
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FIGURE 5.2: graphical representation of the significant interaction between the factors 
group and correspondence (panel A). The overall Simon effect, calculated on correct RT, 
is smaller for young participants, respect to older and patients groups. No differences are 
revealed between old and patients groups (panel B). C= corresponding trials; NC= non-
corresponding trials.* Significant difference refers to a p value <.05. ns: non-significant 
difference. Error bars represent standard errors. 
 
 
Accuracy	   rates. The rANOVA for accuracy rates yielded significant main effects of 
correspondence [F(1,54)=73.42 p<.001 np2 = .57], block [F(1,54)=10.94 p<.005 np2 
=.17], and the following significant interactions: block*correspondence [F(1,54)=10.13; 
p<.005 np2 = .16] and block*group [F(2,54)=5.99; p<.005 np2 = .18]. Fisher post hoc 
comparisons on the first interaction revealed an overall increased accuracy in NC trials 
of the punishment block; post hoc comparisons about the block*group interaction 
showed that only the young group modulated accuracy rates in relation to the block 
(p<.05), with a significant higher accuracy level in punishment condition (see figure 
5.3a). The meaning of a three way interaction block*correspondence*group 
[F(2,54)=4.53; p<.05 np2 = .14] was explored with a post hoc mixed ANOVA on Simon 
effect, with the factors block and group. Fisher post hoc comparisons, conducted to 
explore the significant interaction block*group [F(2,54)=7.83; p<.005 np2 = .22], yielded 
by this additional ANOVA on the Simon effect, showed that only in the young group 
the magnitude of Simon effect was significantly modulated by the block, with greater 
Simon effect in the reward block (p<.001; see figure 5.3b). 
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Boundary	   separation	   (a). A significant effect of correspondence [F(1,53)= 36.4; 
p<.001; np2 = .40] showed that the overall decision process took longer to reach the 
threshold in C trial. The main effect of group [F(2,53)= 20.4; p<.001; np2 =.43] indicated 
increasing a values in aging and in patients, given the significant differences between 
the three groups. The significant block*group interaction [F(2,53)= 8.02; p<.005; np2 
= .23] showed a different block modulation of a parameter in the three groups. Post hoc 
comparisons revealed that in young participants boundary separation, i.e. a parameter, 
increased in the punishment block, respect to the reward one. An opposite pattern was 
found in the old group (figure 5.4a) while no differences were found in PD patients, 
which showed absence of modulation of a parameter by the block. The significant 
block*correspondence* group interaction [F(2,53)= 3.19; p<.05; np2 = .10], and post hoc 
comparisons, revealed these block depending modulation of a parameter, found in 
young and old groups, was driven by C trials responses. In C trials of the punishment 
block, young and older adults respectively showed higher and lower boundary 
separation, in comparison to C trials of the reward block. 
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A)	  	  	  	  accuracy	  in	  the	  two	  blocks	  
	  *	  
FIGURE 5.3: graphical representation of significant block*group. Panel A: young 
participants modulated accuracy levels depending from the block type. Panel B: young 
participants showed a greater Simon effect in the reward block. * Significant difference 
refers to a p value <.05. Error bars represent standard errors. 
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Response	   bias	   (z/a). The main effect of block [F(1,53)= 34.15; p<.001; np2 = .39] 
and the block*group interaction [F(2,53)= 19.14; p<.001; np2 = .41] showed that young 
and older adults were significantly biased in favour of the correct response in the 
punishment block, while no difference was found in PD patients group (figure 5.4b).  
In addition, the main effect of group [F(2,53)= 14.21; p<.001; np2 = .34] revealed that 
while response bias values were significantly higher in older adults (z/a = .74), 
compared to young (z/a = .61), patients showed significantly lower values (z/a = .53) 
respect to the older adults group.  
 
 
 
 
 
 
FIGURE 5.4: decisional parameters of the diffusion model. Panel A: graphical 
representation of the block*group interaction, yielded by the analysis of boundary 
separation. Panel B: block*group interaction in the response-bias analysis. The dotted line 
indicates absence of response bias: values above the line indicate a bias for correct 
response. * Significant difference refers to a p value <.05. Error bars represent standard 
errors. 
 
 
Non-­‐decision	  time	  (t0). The main effect of group [F(2,53)= 8.19; p<.005; np2 =.23] 
showed that the mean non-decision time was significantly higher for PD patients, 
respect to both young and older adults group (p<.05; Figure 5.5a). 
 
Drift	   rate	   (v). A significant effect of block [F(2,53)= 9.76; p<.005; np2 = .15] 
indicated that overall drift rate values were higher in the punishment block respect to 
the reward one.  
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The main effect of correspondence [F(1,53)= 26.25; p<.001; np2 =.33] showed as the 
drift rate was lower for non-corresponding than for corresponding trials. Finally the 
main effect of group [F(2,53)= 22.75; p<.001; np2 = .46], and following post hoc 
comparison, revealed that PD patients showed significantly lower drift rate values, 
comparing with young and older adults groups (figure 5.5b; p<.005).  
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 5.5: non-decisional model parameters. Panel A: non-decision time in the three 
groups. Panel B: drift rate in the three groups. * Significant difference refers to a p value 
<.05. Error bars represent standard errors. 
 
	  
5.4	  Discussion	  and	  conclusion	  	  	  
The present study aimed at investigating if, and how, the presence of different 
motivational incentives can modulate the performance in a conflict task. Our goals were 
to explore the interaction between cognitive-control mechanisms and motivational 
variables employing a new paradigm, the “motivational Simon task”, and adopting a 
detailed analysis approach, the diffusion model analysis (Ratcliff, 1978). With the 
diffusion model analysis in fact we wanted to explore the detail of the interaction 
between motivation and cognitive control, to understand which components of the 
performance can be modulated by motivational incentives.  
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Important objective of this study was then to adopt this new task and the diffusion 
model analysis to explore if, and how, the interaction between motivation and cognitive 
control can change during ageing, and can be impaired in medicated PD patients. Before 
submitting data to the diffusion model analysis, RT and accuracy rates were evaluated. 
Results about RT performance first of all indicated that the motivational Simon task is a 
valid measure of cognitive control, yielding significant Simon effects in spite of the 
introduction of inter-trial stimuli, i.e. the feedbacks. Analysing group differences, RT 
data showed that in spite of the significant slowing, both older adults and PD patients 
manifested increased cost of conflict processing, showing a greater Simon effect respect 
to young, in line with previous findings (Paxton et al., 2008; Schmiedt-Fehr et al., 2006; 
Braver & Barch, 2002; Van der Lubbe & Verleger, 2002). Nevertheless, RT data did 
not show any effect of the motivational incentives in cognitive control measures.  
A first index of interaction between motivation and cognitive control was showed 
however in the analysis of accuracy rates. Our results indicated that the young group 
modulated their performance in relation to the motivational incentive, with higher 
accuracy and smaller Simon effect when errors were penalized, i.e. in the punishment 
block. Old healthy subjects and medicated PD patients did not modulate overall 
accuracy and conflict processing in response to different motivational contexts. 
Even if these first results indicated interesting difference between the three groups 
tested, it was with the diffusion model analysis, which combined RT and accuracy 
values, that we had more precise information. 
First result of the diffusion model analysis concerned the decisional parameters. Results 
showed that the overall response style changed in the three groups, with an increasing 
“conservatory” approach going from young, to old and PD patients. Nevertheless, the 
old group showed the higher bias in favour of correct responses, while young 
participants and PD patients showed an almost absent bias. More importantly, young 
and old healthy participants modulated their response style and response bias depending 
on the block, which is supposed to induce different motivational status. These results 
indicated that PD patients did not show any difference depending on the block.  
While in healthy condition the presence of motivational incentives impacts on the 
executive stages of information processing, in medicated PD patients this modulation 
seems to be absent.  
Concurrently with these findings, the analysis of extra-decisional parameters added 
important information to understand this complex pattern.  
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Between group comparisons showed that old subjects did not spend more non-decision 
time respect to the younger. On the contrary, PD patients showed higher non-decision 
time comparing with both young and old subjects. Furthermore, while the performance 
of old and young subjects was comparable in terms of perceptual efficiency, PD patients 
showed a significantly slower information processing. In spite of these group 
difference, the analysis of these parameters showed as motivational incentives did not 
modulate the extra-decisional components of the performance, in none of the three 
groups. 
Taken together, our results suggest that healthy people are able to modulate their 
performance depending on a motivational incentive, and that ageing do not affect this 
capacity, in line with previous works (Spaniol et al., 2011; Harsay et al., 2010). Even if 
adopting a different approach to the task respect to young people, old subjects show a 
preserved capacity to manage their resources in response to different motivational 
conditions. The different pattern of performance that we found between young and old 
participants is in line with literature about ageing differences in speed-accuracy 
balancing and decision-making: young generally perform quickly and are more 
accepting of errors, while old respond slowly trying to be more accurate (Starns & 
Ratcliff, 2010; Smith & Brewer, 1995; Hertzog et al., 1993; Baron & Matilla, 1989; 
Salthouse, 1979). What is important to highlight is that the capacity to modulate the 
performance in response to a motivational incentive is preserved in ageing, with an 
efficient modulation of the executive components of the performance, as what happens 
for young healthy people.  
On the other hand, medicated PD patients without dementia, but with EF impairment, 
show an altered capacity to modulate the performance depending on motivational 
incentives. In this pathology, EF decline and also dopaminergic treatment could have 
worked together to create a complex pattern of dysfunctional performance. As briefly 
described above, the capacity to integrate motivation and cognitive control seems to be 
the result of a complex integration between EF, primarily sustained by the prefrontal 
cortex and anterior cingulate cortex activity, and the feedback processing capacity, in 
which the dopaminergic system has critical role. In PD, a dopaminergic dysregulation, 
subsequent to both aetiology and pharmacological treatment, can result in a generalised 
EF decline that affect goal-driven behaviour.  
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Even if our study can’t address specific causal relations, EF and reward processing 
deficits (Kudlica et al., 2011; Kapogiannis et al., 2011; Bodi et al., 2009; Kobayakawa 
et al., 2010; Frank et al., 2007-2004) can be the reasons of the impaired motivational 
modulation of the performance showed by the results of the present study.  
These final results have also important clinical implications. Investigating the 
interaction between motivation and cognitive control, results of the present study 
indicate that PD patients are unable to modulate their resources in response to 
performance-contingent feedbacks. In the light of the fact that in clinical 
neuropsychology most cognitive rehabilitation procedures are based on feedback-
guided learning, where symbolic feedbacks, contingent upon performance, are used to 
motivate the performance of a patient, our study show a possible fallacy of that trend in 
this clinical condition. Feedback-based learning could be the wrong method to set a 
cognitive rehabilitation procedure if the subject of the therapy has EF deficits an, 
moreover, an altered feedback processing capacity.  
In conclusion, our findings add information about mechanisms that underlie the 
function of motivational incentives in modulating the management of cognitive 
resources. In healthy condition, motivational incentives can modulate the decisional 
parameter of a performance and then the management of cognitive resources. On the 
contrary, when an EF decline compromise feedback processing capacity, the interaction 
between motivation and cognitive control can be inefficient.  
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CHAPTER	  VI	  -­‐	  THIRD	  STUDY	  
EXECUTIVE	  FUNCTIONS	  AND	  DECISION	  MAKING:	  AN	  ERPs	  ANALYSIS	  OF	  
FEEDBACK	  PROCESSING	  IN	  PARKINSON’S	  DISEASE	  	  
6.1 	  	  	  Introduction	  	  
A definition of the term “decision-making” could not be easy, because it represents one 
of the highest and most complex human abilities that is classically included in the EF 
“family”. According to Rogers (2011) we intend decision making as a complex process 
that  “encompasses a range of functions through which motivational processes make 
contact with action selection mechanisms to express one behavioural output rather than 
any of the available alternatives”. This definition implicitly assumes that the decision 
process is based on the functions of selection and inhibition, working memory, planning, 
emotion, estimation and every process included in the term “executive control”. 
Research about decision-making within cognitive neuroscience has largely increased 
over the last 20 years, starting from the study of patients with frontal lobe damage 
(Bechara et al., 1996-1994; Damasio, 1994), to the emergence of new disciplines as 
neuroeconomics (Glimcher et al., 2008). Even though this increasing interest has been 
accompanied by the development of divergent models, a consensus has been reached 
concerning some of the fundamental aspects of decision-making. Form a cognitive 
psychology point of view, decision-making can be considered as the integration of three 
complementary abilities, summarized by Fang and colleagues (2009) which are: choice 
evaluation, response selection and feedback processing; in our opinion of these three 
abilities the last one has a crucial influence on the first two. In fact, before selecting or 
inhibiting an option, this should be evaluated and processed, and a correct connotation 
with positive or negative valence is possible only on the base of previous outcome 
evaluation experiences. The evaluation of our action outcomes and their anticipation 
appears then to be crucial for choice evaluation and for response selection, i.e for an 
efficient decision process. According to a more complete cognitive neuroscience point 
of view, it is shared knowledge that in normal decision-making an extended neural 
network is required, mainly comprising the prefrontal cortex (PFC) but including also 
the fronto-striatal and limbic loops, subcortical structures as basal ganglia, amygdala 
and anterior cingulate cortex (for a review see Gleichgerrcht et al., 2010; see figure 6.1). 
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Considering the important contribution of neurotrasmettitorial systems in this network, 
it is possible to affirm that dopamine (DA) plays a key role in decision-making process 
(Rogers, 2011; Assadi et al., 2009). Despite its multi-faceted influence upon decision-
making (Rogers, 2011), DA transmission has a crucial function in reward processing 
during reinforcement learning (Frank et al., 2004; Schultz, 2002) and the importance of 
the fronto-striatal system in learning and outcome monitoring is even more recognized 
(Hämmerer & Eppinger, 2012). Without going into details of the DA functioning in the 
reward circuit and in the decision-making network, there is considerable evidence for 
the idea that decline in dopaminergic neuromodulation affects outcome monitoring 
(Hämmerer & Eppinger, 2012) with possible result of an overall impairment in 
decision-making ability.  
 
 
 
FIGURE 6.1. Simplified neuroanatomical model of decision-making (adapted from 
Gleichgerrcht et al., 2010). Three main systems are thought to be involved in decision-
making capacity: stimulus encoding (orbitofrontal cortex- red), action selection (anterior 
cingulate cortex- green) and reward processing (basal ganglia and amygdala- blue). These 
regions work together with the PFC, parietal cortex and other subcortical structures as 
the insula.  
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Impaired decision-making abilities have been documented in many different clinical 
conditions, mainly in situations in which PFC was compromised. For example, evident 
decision-making impairment was firstly described in patients with frontal lobe damage (Fellows & Farah, 2005; Bechara et al., 1996-1997) or patients with fronto-temporal 
dementia (Torralva et al., 2009-2007; Rahman et al., 2005-1999), while interest in the 
decision-making capacity in healthy aging (Eppinger et al., 2011; Cauffman et al., 2010; 
Kovalchik et al., 2005; Finucane et al., 2002; MacPherson et al., 2002; Yates & 
Palatano, 1999) has also increased.  
Parkinson’s disease (PD) represents a clinical condition of particular interest in this 
research field because both aetiology and pharmacological therapies involve 
dopaminergic transmission and functionality of fronto-striatal system. More importantly, 
a growing recent literature is documenting the presence of feedback processing deficits 
in PD patients (Kapogiannis et al., 2011; Bodi et al., 2009; Kobayakawa et al., 2010; 
Frank et al., 2007-2004), concurrently with the development of cognitive and 
behavioural deficits linked to the impulse control disorder spectrum (for a review see 
Poletti & Bonuccelli, 2012). The application of one of the most common decision-
making task, the Iowa Gambing Task (IGT; Bechara et al., 1994) in PD patients gave 
divergent results (Dirnberger & Jahanshahi, 2013, Poletti et al., 2011). Four studies with 
non-demented PD patients found non-significant impairments on the IGT (Poletti et al., 
2010; Euteneuer et al., 2009; Thiel et al., 2003; Czernecki et al., 2002), whereas five 
studies showed that PD patients had a worse performance than healthy controls 
(Gescheidt et al., 2012; Kobayakawa et al., 2010-2008; Pagonabarraga et al., 2007; 
Mimura et al., 2006; Perretta et al., 2005). Three of these studies found non-significant 
effects of dopaminergic medication on the IGT performance in PD patients 
(Kobayakawa et al., 2010; Perretta et al., 2005; Czernecki et al., 2002;). Even if 
different decision-making tasks were used, findings are still divergent: patients with PD 
are impaired particularly when ‘on’ dopaminergic medication in the study of Euteneuer 
and colleagues (2009) or in the work of Cools and colleagues (2003), whereas PD 
patients without medication were impaired according to Brand (Brand et al., 2004). On 
the contrary Delazer and colleagues (2009) did not find any decision-making 
impairment in PD patients.  
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On the basis of these contrasting data, our goal is to add evidence in this field, by 
exploring in PD patients one of the crucial aspects of decision-making ability, i.e. the 
outcome evaluation, and trying to overcome limits and discrepancies of previous studies.  
We employ once again the IGT (Bechara et al., 1994) that, without giving the 
knowledge about what the probabilities of certain outcomes are, represents a task that 
properly simulates the uncertainty of decision-making, typical of real life activities. 
Nevertheless, we chose a new approach: for the first time with PD patients, during the 
IGT execution we record the electroencephalogram activity. The goal of this study is in 
fact to evaluate the neural correlates of feedback processing using the Event Related 
Potential (ERPs; see box 3 for detail about this technique), with the aim of obtaining 
more information about underlying mechanisms of a possible impairment in decision-
making. In detail, our objective is to explore the ERPs modulations related to the 
outcome of the decision, evaluating feedback-related negativity (FRN) and P3. These 
two ERPs components, in fact, are differentially modulated by the valence of an 
outcome and, for this reason, they are usually considered as electrophysiological 
markers of feedback processing. While FRN was shown to be sensitive to the valence of 
the feedback, with larger amplitude after negative than after positive feedback P3 is 
sensitive to both magnitude and valence of feedback with larger P3 after positive 
feedback than after negative (Ferdinand & Kray, 2013; Wu & Zhou, 2009; Hajcak et al., 
2006; Holroyd et al., 2006; Toyomaki & Murohashi, 2005; Yeung & Sanfey, 2004; 
Gehring & Willoughby, 2002). Furthermore, while FRN reflects an early appraisal of 
feedback on a binary classification basis of good vs. bad outcomes, P3 seems to reflect a 
later, top-down controlled feedback evaluation process (Cui et al., 2013). As confirmed 
by a recent work by Cui and colleagues (2013), the recording of ERPs during the IGT 
represents a good method for the evaluation of these two electrophysiological markers 
of feedback processing, and for this reason we applied this methodology with PD 
patients. We predict that the results will be consistent with our previous study (see 
previous chapter) and we expect to find a difference in the electrophysiological patterns 
between PD patients and healthy control subjects. 
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Box	  3:	  EVENT	  RELATED	  POTENTIALS	  (ERPs)	  
Event-­‐Related	  potentials	  (ERPs)	  are	  small	  fluctuations	  in	  the	  electrical	  activity	  of	  the	  
brain,	  which	  are	  related	  to	  a	  specific	  sensory,	  cognitive,	  or	  motor	  event	  (Luck,	  2005).	  
Recording	  electroencephalographic	  (EEG)	  activity	  during	  a	  time	  window	  that	  is	  time	  
locked	  to	  the	  presentation	  of	  a	  stimulus,	  it	  is	  possible	  to	  record	  voltage	  changes,	  
which	  are	  specifically	  linked	  to	  the	  brain’s	  response	  to	  that	  stimulus	  (Coles	  &	  Rugg,	  
2002).	  These	  voltage	  changes	  reflect	  the	  summation	  of	  postsynaptic	  potentials	  and	  
constitute	  the	  scalp	  recorded	  ERPs.	  
	  
ERPs	  VOCABULARY	  
EPOCH:	   	   the	   defined	   time	   window,	   which	   is	   time	   locked	   to	   the	   occurrences	   of	   a	  
particular	  event	  or	  stimulus	  during	  the	  EEG	  recording.	  
FILTERING:	   data-­‐processing	   technique	  necessary	   to	  extract	   the	  ERP	   signal	   from	   the	  
on-­‐going	  EEG.	  Analogue	  or	  digital	  filters	  can	  be	  used	  at	  the	  time	  of	  recording	  and/or	  
at	   the	   time	   of	   analysis,	   to	   attenuate	   activity	   outside	   the	   frequency	   of	   interest.	   In	  
most	  cognitive	  experiments,	  the	  ERPs	  of	  interest	  are	  composed	  mostly	  of	  frequencies	  
under	  about	  30	  Hz	  (Luck,	  2005).	  
AVERAGING:	   signal-­‐processing	   procedure	   necessary	   to	   extract	   the	   ERP	   signal	   from	  
the	  on-­‐going	  EEG.	  Averaging	   procedure	   is	  based	  on	   two	   fundamental	   assumptions:	  
the	  neural	  activity	  related	  to	  the	  time-­‐locking	  event	   is	  the	  same	  on	  every	  trial;	  only	  
the	   EEG	   noise	   varies	   from	   trial	   to	   trial	   (Luck,	   2005).	   Averaging	   involves	   the	  
summation	  of	  a	  number	  of	  EEG	  epochs,	  considered	  the	  product	  of	  both	  the	  ERP	  and	  
other	   voltage	   variations	   that	   are	   not	   time-­‐locked	   to	   the	   event.	  On	   the	   assumption	  
that	  EEG	  activity	  that	  is	  not	  time-­‐locked	  to	  the	  event	  varies	  randomly	  across	  epochs,	  
the	  background	  EEG	  averages	   to	   zero	   leaving	  a	   residual	  waveform	   that	   reflects	   the	  
electrical	   activity	   that	  has	  a	   fixed	   temporal	   relationship	   to	   the	  event	  across	  epochs	  
(Coles	  &	  Rugg,	  2002;	  Fabiani	  et	  al.,	  2000).	  
WAVE:	  with	  the	  term	  wave	  or	  waveform	  it	  means	  a	  series	  of	  positive	  and	  negative	  
voltage	  deflections,	  which	  result	  from	  the	  averaging	  process.	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AMPLITUDE:	   this	   term	   indicates	   to	   the	   magnitude	   of	   the	   signal	   recorded,	   and	   is	  
considered	   as	   the	   expression	   of	   the	   level	   of	   neural	   activation.	   ERPs	   amplitude	   is	  
measured	  in	  micron	  volt	  (μV).	  	  
LATENCY:	  refers	  to	  the	  temporal	  dimension	  of	  the	  waveform	  recorded.	  ERPs	  latency	  
is	  usually	  defined	  as	  the	  time	  from	  the	  stimulus	  onset	  and	  is	  measured	  in	  millisecond	  
(ms).	  
PEAK:	   this	   term	   is	   used	   to	   indicate	   the	  most	   positive	   and	   negative	   deflections,	   in	  
terms	   of	   amplitude,	   which	   characterise	   the	   ERPs	   wave.	   Peaks	   can	   be	   labelled	  
according	  to	  their	  amplitude	  and	  latency.	  The	  letters	  P	  and	  N	  traditionally	  refer	  to	  the	  
amplitude,	   designating	   positive-­‐going	   and	   negative-­‐going	   peaks	   respectively.	  
Referring	  to	  their	  ordinal	  or	  temporal	   latency,	   letters	  P	  and	  N	  can	  be	  followed	  by	  a	  
single	   digit	   (e.g.	   N1,	   P3),	   which	   refers	   to	   the	   peak’s	   ordinal	   position	   within	   the	  
waveform.	  
COMPONENT:	   ERPs	  components	  can	  be	  defined	  operationally	  as	  a	  part	  of	  the	  ERPs	  
waveform	  with	  delineated	  scalp	  distribution	  and	  delineated	  relation	  to	  experimental	  
variables	  (Otten	  &	  Rugg,	  2005).	  Even	  if	  components	  are	  commonly	  labelled	  referring	  
to	   their	   amplitude	   and	   latency	  within	   the	  waveform,	  as	  happens	   for	   the	  peak,	   the	  
term	   component	   refers	   also	   to	   the	   sensory	   or	   cognitive	   process	   involved	   in	   the	  
recorded	  ERPs	  activity.	  The	  amplitude	  of	  a	  component	  is	  commonly	  measured	  in	  one	  
of	  two	  ways:	  as	  peak	  amplitude,	  measuring	  the	  amplitude	  at	  the	  peak	  latency,	  or	  as	  
mean	  amplitude,	  computing	  the	  average	  amplitude	  over	  a	  time	  window	  that	  contains	  
the	   component	   of	   interest.	   Because	   peak	   amplitude	   measures	   are	   particularly	  
sensitive	   to	   noise	   in	   ERP	   waveforms,	   mean	   amplitude	   measures	   are	   preferable	   in	  
situation	  of	  noise,	  for	  example	  in	  the	  comparisons	  between	  conditions	  with	  unequal	  
number	  of	  trials,	  or	  in	  between	  groups	  comparisons,	  where	  the	  data	  from	  one	  group	  
might	  be	  noisier	  than	  the	  data	  from	  the	  other	  one.	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6.2	  Method	  
 
Participants	  
Twenty-eight participants were recruited: fifteen (11 male) healthy subjects (age range 
43-77 years; mean= 60.7 sd= 9.8) and thirteen (10 male) PD patients (age range 47-73 
years; mean= 62.6 years, sd=8.3) participated in the study. Both PD patients and older 
adults were recruited in the Pederzoli Hospital, in Peschiera del Garda (Verona-Italy). 
The PD patients fulfilled formal diagnostic criteria for PD according to the Unified 
Parkinson’s Disease Rating Scale (UPDRS; Fahn & Elton, 1987; Goetz et al., 2003), 
had mean disease duration of 4.9 years (range of onset 1–14 years, sd=3.4) and a mean 
estimated motor sub score of 8.8 (range 3-16, sd= 4) on the UPDRS. Patients were 
asked to continue taking their medication at the required time on the day of testing. Five 
patients received dopamine precursors (levodopa), two patients were receiving 
dopamine agonists, four received a monoamine oxidase inhibitor (MAOI), and two 
patients were taking a combination of levodopa and dopamine agonists. Healthy 
subjects and PD patients were matched for age, gender, education and MMSE score (see 
table 6.1) and for this reason the healthy subjects will be considered as control group. 
All participants gave signed informed consent after the purpose of the study and the 
protocol had been explained to them. 
 
TABLE	  6.1	  Means	  and	  standard	  deviations	  of	  matched	  demographical	  characteristics	  
and	  MMSE	  score	  in	  PD	  patients	  and	  control	  group.	  
	  	   PD	  patients	  	  
N=	  13	  
Control	  group	  
N=	  15	  
Test	  
(df)	  
p-­‐value	  
Age	  (years)	   62.6	  ±	  8.3	   60.7	  ±	  9.8	   t	  (26)=.547	   .ns	  
Gender	   10	  M	   11	  M	   x2(1)=1.19	   .ns	  
Education	  (years)	   8.7	  ±	  3.6	   11.4	  ±	  4.3	   t	  (26)=-­‐1.72	   .ns	  
MMSE	  score	   28.2	  ±	  1.3	   27.86	  ±	  1.5	   t	  (26)=.666	   .ns	  
MMSE: Mini Mental State Examination (Folstein et al., 1975) 
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Exclusion/Inclusion	   criteria. Inclusion criteria for this study were participants with 
normal or corrected to normal vision. Exclusion criteria applied in the recruitment of the 
control group were the presence of neurological disease (any medical conditions 
associated with a head injury, epilepsy, stroke), reported history of psychiatric disorder 
or neurological disease and use of psychiatric and neurological medications. Finally, for 
both patients and control group exclusion criterion was a Mini Mental State 
Examination (MMSE; Folstein et al., 1975) score under the cut-off (24).  
 
Measures	  
Iowa	  Gambling	  Task. Decision-making was assessed using the Iowa Gambling Task 
(IGT; Bechara et al., 1994). This test was developed in the Iowa University to assess 
decision-making capacity in laboratory environment. Even if it was originally designed 
in analogical mode, in our study the IGT was implemented in a computerized version. 
The experiment ran with the E-Prime 2 software (Psychology Software Tools, 
Pittsburgh, PA) installed on a personal computer equipped with a 17” monitor.  
The task consisted in the presentation, on a computer screen, of four decks named A, B, 
C and D. Each card in these decks can bring a win or a loss: participants were requested 
to gain as more as possible, choosing consecutively one card from any of the four decks, 
until the task shuts off automatically after 100 cards. The back of each deck looks the 
same, but they differ in composition. Decks A and B are considered disadvantageous, 
because they brought to big wins but also expensive losses, producing a net loss of 250€ 
in 10 cards. Deck C and D are considered advantageous decks because brought small 
wins, but smaller losses, causing a net gain of 250€ in block of 10 cards. The 
instructions given to the participants were the following: “ in this screen you can see 
four decks, two are advantageous and two are disadvantageous. Each card of these 
decks can bring a win or a loss:  the goal of this task is to win as much money as 
possible, and avoid losing money as much as possible, starting from a virtual budget of 
2000 €.” Participants did not know the number of choices and, moreover, which were 
the advantageous or the disadvantageous decks. Participants saw on the screen the 
amount of money that they won or loose; this amount was updated after each choice. 
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EEG	   recording. While participants performed the IGT, the electroencephalogram 
(EEG) was acquired from an array of 32 Ag/AgCl electrodes, through a Micromed 
electrode system. Electrodes were identified by brain hemisphere (odd numbers = left, 
even numbers = right) and general cortical zone (F = frontal, C = central, T = temporal, 
P = parietal, and O= occipital). 30 electrodes were mounted on an elastic cap, according 
to the International 10–20 system (Oostenveld & Praamstra, 2001; see figure 6.2).  
Left and right mastoids served as reference, while the vertical and horizontal eye 
movements were recorded with two electro-oculogram (EOG) electrodes, placed below 
and at the outer canthus of the left eye. The ground electrode was located at POz 
channel (GND in the figure 1). Rating sample was 512 Hz, electrodes impedances were 
< 5 kΩ and a digital band-pass filter from 0.1 Hz to 30 Hz was applied off-line. Epochs 
were locked to feedback onset and were 2000 ms long, between 1000 ms before and 
1000 ms after feedback onset.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 6.2: schematic representation of 30 electrodes scalp location (with labels) 
according to the International 10–20 system (Oostenveld and Praamstra, 2001); two 
electrodes were positioned at the left and the right mastoids, as reference, while two 
electrodes were placed below and at the outer canthus of the left eye, to record the electro-
oculogram (EOG). GND corresponds to POz channel. 
	  
LEFT	   RIGHT	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Dependent	  variables	  and	  data	  analysis	  	  
Behavioural	   variables. The IGT performance was evaluated using more then one 
parameters. The first analysis has been conducted exploring the modal value concerning 
decks choices. The preferential choice for each subject of the two groups was calculated, 
and the values were submitted to a Chi square frequency analysis, to evaluate if the 
distribution of choice frequencies was the same in the two groups. To obtain the IGT 
score, according to previous reports (Kobayakawa et al., 2010; Pagonabarraga et al., 
2007; Fukui et al., 2005; Bechara et al., 1994) we subdivided the 100 selections into 
five blocks of 20 cards. For each block, the difference between the number of cards 
selected in advantageous decks (A and B) minus those chosen in disadvantageous ones 
(C and D) was calculated. In this way, five IGT scores were obtained for each 
participant, and the comparison between these values was considered as index of 
learning trend. In fact, increasing values of IGT score from the first to the last block 
indicate a preference for advantageous decks and the learning of the correct response 
strategy. Group differences were investigated submitting IGT scores to a mixed 
ANOVA, with the factors Group (patients and controls) and Time (from the first to the 
fifth block). Bonferroni correction for multiple comparisons was applied. 
 
ERPs	   data. EEG data were processed using EEGLAB (Delorme & Makeig, 2004). 
Epochs were locked to the feedback presentation, and the averaging procedure was 
performed separately for positive and negative feedbacks. Artefacts correction was 
performed using independent components analysis technique (ICA; Makeig et al., 1996). 
The FRN was measured as the peak-to-peak difference between the positivity in the 
time window from 150 ms to 250 ms and the following negativity in a time window 
from 350 ms to 450 ms after feedback presentation. Since the FRN is usually most 
pronounced at fronto-central sites (Gehring & Willoughby, 2002) this measure was 
calculated at electrodes Fz, FCz and Cz and then submitted to a mixed ANOVA, with 
the factors Site (Fz, FCz and Cz), Feedback type (win vs loss) and Group (PD patients 
vs Control group). Mean amplitude of three time windows (150-250 ms; 250-350 ms; 
350-450 ms) calculated at the midline electrodes Fz, Cz and Pz, were selected to 
measure P300 proportionally to FRN component.  
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These values were submitted to a mixed ANOVA, with the factors Interval (150-250 ms, 
250-350 ms and 350-450 ms) Site (Fz, Cz, Pz), Feedback type (win vs loss) and Group 
(PD patients vs Control group). In both these ERPs analysis, Bonferroni correction for 
multiple comparisons was applied. 
6.3	  Results	  	  
Behavioural	  results. Exploring the modal values of deck choices, calculated for each 
subject of the two groups, results showed that the 70% of our patients preferred 
disadvantageous decks; only four patients (30%) preferred disadvantageous decks. On 
the contrary, the control group showed the opposite pattern: on 15 participants, the 80% 
preferred decks C and D, advantageous ones, while only 3 subject (20%) choose as 
preferential deck a disadvantageous (see figure 6.3a). The pattern of these choices was 
significantly different between patients and controls [x2(3)= 9.62; p<.05].  
Evaluating learning trend during the task, the ANOVA on the five IGT scores 
calculated in five blocks of 20 choices (IGT score= number of advantageous choices – 
number of disadvantageous choices), showed a main effect of Time [F(4,104)=12.07; 
p<.001 np2 = .317], a main effect of Group [F(1,26)=6.11; p<.05 np2 = .19]   and a 
significant Time*Group interaction [F(4,104)=4.09; p<.005 np2 = .136]. Post hoc 
analysis revealed within groups differences: while the control group showed significant 
differences between IGT scores, PD patients did not show any differences (see figure 
6.3b). Furthermore the post-hoc analysis also revealed between groups differences: 
despite a better performance of PD patients in the first block (p< 0.05), PD patients had 
a significantly lower IGT score, respect to the control group, in the third, fourth and 
fifth blocks (p<0.05; see figure 6.3c). 
 
ERPs	  results. The feedback-locked ERPs of both groups are displayed in figure 6.4. 
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FIGURE 6.3: behavioural indices of performance at the Iowa Gambling task. Panel A: 
patterns of choice preference in the two groups; numbers represent the subjects who 
choose the deck. Panel B: learning trend in the two groups; Panel C: between groups 
comparison. * Significant difference refers to a p value <.05. Error bars represent 
standard errors.  
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FIGURE 6.4: Grand average ERPs in the anterior (Fz, FCz) central (Cz) and parietal (Pz) sites.  	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FRN. The analysis on FRN recorded by Fz, FCz and Cz channels yielded a main effect 
of Feedback Type [F(1,26) = 11.85, p < .005, np2 = .31] indicating that FRN was larger 
after a loss then after a win. Importantly, in spite of visual data inspection, we found no 
interaction between Group* Feedback Type. 
P300. The analysis of the mean amplitude recorded in the three time intervals after 
feedback onset (150-250 ms, 250-350 ms and 350-450 ms) and at the midline electrodes 
Fz, Cz and Pz, showed main effects of Site [F(2,52) = 3.30, p < .05, np2 = .113] and 
Feedback type [F(1,26) = 7.71, p < .05, np2 = .23]: mean activity between 150 and 450 
ms after feedback onset has higher amplitude at Cz (2.83 µV), comparing with Fz (2.39 
µV) and Pz (1.80 µV). In addition, the ERPs amplitude was greater after positive 
feedbacks (2.84 µV) then negative ones (1.85 µV). The difference between positive and 
negative feedbacks was significant between 250 and 450 ms, as indicated by the 
Feedback*Time interaction  [F(2,52) = 5.14, p= .01, np2 = .165]. Site*Group interaction 
[F(2,52) = 4.85, p < .05, np2 = .156] and subsequent post hoc comparisons, indicated that 
PD patients had a lower (p<.005) amplitude at frontal site (Fz) compared with central 
site (Cz), and a comparable amplitude at central (Cz) and parietal (Pz) sites. On the 
contrary, control group showed a significantly lower activity (p<.05) at the parietal site 
(Pz), comparing with central (Cz) and frontal (Fz) ones (see figure 6.5). 
 
FIGURE 6.5: site*group significant interaction: PD patients had a lower (p<.005) 
amplitude at frontal site (Fz) compared with central site (Cz), showing no differences 
between central and parietal sites (Pz). On the contrary, control group showed a 
significantly lower activity (p<.05) at the parietal site (Pz), comparing with central and 
frontal ones. * Significant difference refers to a p value <.05. Error bars represent 
standard errors. 
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The Site*Feedback type interaction was also significant [F(2,52) = 4.0, p < .05, np2 
= .133], indicating significant differences between positive and negative feedback-
evoked responses in Fz and Pz.  
Finally, a significant interaction Feedback*Time*Group [F(2,52) = 3.45, p < .05, np2 
= .117] indicated that PD patients and control group presented different feedback-
evoked responses. Post hoc comparisons specified that in the control group the mean 
amplitude, of both the time windows 250-350 ms and 350-450 ms, was significantly 
different after positive and negative feedbacks (p<.05). On the contrary, in PD patients 
non-significant differences between feedback-evoked responses were revealed (see 
figure 6.6).  
 
 	  	   	    
  
 
 
 
 
 
 
 
 
FIGURE 6.6: Feedback*Time*Group interaction: significant difference in the control 
group between win and loss evoked response, in both the time windows between 250-350 
ms and 350-450 ms. No differences in PD patients group. * Significant difference refers to a p 
value <.05. Error bars represent standard errors. 
 
	  	  
6.4	  Discussion	  and	  conclusion	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In the current study we examined the neural correlates of feedback processing in a 
sample of PD patients, employing the ERPs technique during the IGT (Bechara et al., 
1994), a task that simulates in a laboratory environment an uncertain decision-making 
situation. In detail, we explored the performance of a group of PD patients under 
dopaminergic treatment without cognitive impairment, analysing both behavioural and 
electrophysiological correlates of decision-making. Our aim was to add evidence in the 
exploration of cognitive and behavioural problems manifested in this clinical condition, 
especially in the light of a disagreeing literature background.  
Our results indicate that medicated PD patients had a lower performance in the IGT 
(Bechara et al., 1994), compared to a matched control group. During the task PD 
patients showed a marked preference for disadvantageous choices. This kind of 
preference compromised the entire performance: even in the final phase of the task, PD 
patients continued to choose cards from the decks that had higher returns even if such 
choices were riskier, demonstrating a deficient capacity to learn and follow a successful 
strategy to improve their performance. These behavioural data support those previous 
studies that demonstrated an impaired performance of PD patients on the IGT 
(Gescheidt et al., 2012; Kobayakawa et al., 2010; Pagonabarraga et al., 2007; Perretta et 
al., 2005) but they do not add further information about possible reasons of this poor 
performance. With the aim to better explore the reason of this impairment, we recorded 
EEG activity during the task, evaluating in detail one of the abilities in the decision-
making process, i.e. the feedback processing (Fang et al., 2009).  
 
Analysing ERPs data in relation to feedback processing, FRN and P3 were evaluated in 
PD patients and in a group of matched healthy controls. Our results show no differences 
in FRN between PD patients and control group: all the subjects tested in this study 
manifested a comparable morphology for this component, with larger amplitude after a 
negative feedback, the loss, than after a positive feedback, the win.  
Despite this absence of difference in FRN, when analysing the mean amplitude of the 
same time interval considered for its calculation, i.e. from 150 ms to 450 ms after 
feedback presentation, it emerged an interesting pattern of differences both within and 
between groups.  
 
Even though no overall amplitude differences were found between the two groups, 
elderly healthy subjects showed a higher frontal and central activity in comparison to 
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the activity recorded by a parietal site; on the contrary, PD patients had a lower frontal 
activity, in comparison to the central and parietal ones. These differences in the shift of 
the signal distribution show an interesting finding: while our healthy elderly subjects 
showed a classical anterior-posterior asymmetry, a well-known finding in older adults 
and often interpreted in terms of compensatory resource allocation (Ferdinand & Kray, 
2013; Daffner et al., 2011- 2006; Adrover-Roig & Barceló, 2010; Reuter-Lorenz & 
Lustig, 2005), our PD patients displayed a different recruitment of neural resources, 
with an opposite asymmetry. This could be interpreted as a failure of PD patients in this 
compensatory mechanism, probably due to a compromised PFC functioning. 
Furthermore, from the analysis of the mean amplitude in this time window, our results 
revealed a group difference in feedback related modulation of P3 component. In the 
control group the mean amplitude recorded between 250 and 450 ms after feedback 
onset was significantly modulated by the valence of the outcome, but in PD patients 
there were no differences between positive and negative feedback-evoked responses. 
This means that while older adults showed larger P3 amplitudes after positive than after 
negative feedback, PD patients displayed the same response after both feedbacks. This 
finding suggests that PD patients do not correctly discriminate the valence of an 
outcome and the fact that this absence of valence modulation manifests itself only in the 
later stage of the ERPs response, assumes a particular importance. 
 
According to literature, the P3 is thought to reflect an evaluation process associated 
with working memory updating (Polich, 2007- 2004; Donchin & Coles, 1988) and the 
so called “positivity effect”, i.e. larger P3 amplitude after positive than after negative 
feedback, was supposed to reflect the evaluation of a positive feedback as more task 
relevant, because it signals that the intended goal has been achieved (Ferdinand & Kray, 
2013; see also Bellebaum & Daum, 2008).  
We agree in accepting FRN as an index of expectancy violations rather than an absolute 
valence classification (Alexander and Brown, 2011; Jessup et al., 2010; Oliveira et al., 
2007; Holroyd et al., 2006) and in interpreting the P3 as a component sensitive to 
valence and relevance of feedback that reflects the context updating process and that 
contributes to performance monitoring evaluating the task-relevant feedback which can 
then contribute to behavioural adaptation (Ferdinand & Kray, 2013). 
 
Considering the above statements, we can summarize our results with the following 
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conclusion: while an early appraisal of feedback appears to be preserved, a top-down 
controlled feedback evaluation process seems to be compromised in medicated PD 
patients. Their comparable response to positive and negative outcomes of a choice 
would reflect an altered capacity to discriminate and evaluate the task-relevant 
information, with resultant impairment in choice evaluation and action selection, i.e. a 
compromised decision-making ability. 
As far as we know, there is no other research that has examined the feedback related 
ERPs patterns of PD patients in the IGT, and our results add important information to 
the understanding of the poorer performance of these patients in this task.  
Taken together, our results are in line with the growing literature about feedback 
processing abnormalities in PD patients (Kapogiannis et al., 2011; Kobayakawa et al., 
2010; Bodi et al., 2009; Frank et al., 2007-2004) and suggest that in PD patients an 
incorrect evaluation of context-relevant outcome could be the reason of a poor 
performance in this decision-making task, and may be one of the reasons for the 
development of cognitive and behavioural problems related to impulse control disorder. 
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CHAPTER	  VII	  
GENERAL	  DISCUSSION	  AND	  CONCLUSIONS	  	  
The goal of the present work was to investigate executive functions (EF) in ageing and 
in Parkinson’s disease. In detail our aim was to investigate working memory (WM) and 
feedback processing in healthy elderly and in medicated Parkinson’s disease (PD) 
patients, in order to explore two cognitive abilities related with the dopaminergic 
systems (Hämmerer & Eppinger, 2012; Bäckman et al., 2010-2006; Bäckman & Farde, 
2005). In this way EF were explored in a condition of decreased dopaminergic 
functionality, i.e. in healthy ageing, and in a condition of possible dopaminergic 
“dysregulation”, i.e. in medicated PD patients.  
          In the first study a new task was employed to evaluate the top down components 
of WM. More specifically we evaluated the capacities to focus the resources on task 
relevant information and to inhibit the irrelevant one, essential capacities for conflict 
resolution in WM. The task employed was designed as a “Stroop-like paradigm”, where 
relevant and irrelevant information were combined in congruent or incongruent manner 
to create conflict situations, with the aim of inducing interference and facilitation effects. 
Age-related differences in WM were investigated applying the paradigm to three groups 
of healthy subjects: young, adults and old participants. On the other hand, the 
exploration of dopaminergic “dysregulation” effects in WM was possible applying the 
paradigm in a group of medicated PD patients, matched for age, gender and education 
with the healthy old participants. Our results showed lifespan differences in executive 
attention and inhibition components of WM. Healthy adults showed interference effect 
in their accuracy performance while, older adults showed facilitation effect in term of 
both latency and accuracy. These results confirmed the presence of an age-related 
decline in top down components of WM: the inhibitory control seems to be not 
perfectly efficient in adult and old subjects, as it is in younger people, when the 
information to inhibit is symbolic and not perceptual. In adults and old people, transient 
information stored in WM had detrimental effects on performance. Even if adults 
seemed to control their performance in terms of latency, both adult and older people 
were exposed to “capture errors” (Reason, 1990; Rasmussen, 1982), which were the 
most representative index of the failure to inhibit the irrelevant information. 
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This failure became evident through significant interference effects in adult, and 
through significant facilitation and interference effects in older people. The fact that 
facilitation and interference emerged differently during the lifespan could support the 
existence of two different mechanisms on the base of these effects (Lindsay & Jacoby, 
1994), which could undergo independently to the age-related decline.  
A group of medicated PD patients underwent the same experimental paradigm. PD 
patients tested in this study, which were under dopaminergic treatment and manifested a 
poorer performance in classical EF tests, showed a different pattern of performances in 
the experimental paradigm, respect to their control group. For what concerns accuracy 
rates, PD patients showed significant facilitation and interference effects and, moreover, 
they manifested an increased sensitivity to the irrelevant information, respect to the 
control group. PD patients in fact, even if with comparable overall accuracy, showed 
different accuracy rates depending on the congruence of the information stored in 
working memory, with significantly more errors in incongruent conditions. Despite that, 
PD patients did not show any significant effect of the irrelevant information in terms of 
latency. While the control group showed significant facilitation effects measured by 
response times, PD patients showed significant effects of the irrelevant information only 
in the accuracy. This pattern of results could be plausible in the light of the evidences 
about the role of dopaminergic medication on WM tasks (see Moustafa et al., 2008). 
Even if their accuracy was influenced by irrelevant information, PD patients seemed to 
be more able to control their performance in terms of latency. 
In summary, the results of the first study highlighted the presence of age-related decline 
in top down components of WM, like executive attention and inhibitory control, in line 
with findings about age-related vulnerability to interference and decline in WM (Reuter-
Lorenz & Sylvester, 2005). In addition, the results of this study showed as medicated 
PD patients performed like a control group in terms of accuracy, but better in terms of 
latency. Without comparing the performance of the same patients in an “off” condition, 
we cannot talk about the role of dopaminergic medication in this specific pattern of 
performance. However, our data are in line with previous findings about a double role 
of dopaminergic medications, which might lead to enhancements or impairments in 
WM tasks (Moustafa et al., 2008). Doing a speculation, in our PD patients the 
dopaminergic medication could have enhanced motor functions	  but, concurrently, could 
have impaired or, at least, could have not enhanced their ability to inhibit irrelevant 
information transiently encoded in WM.   
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       In the second study, a different new task was employed to study feedback 
processing in healthy ageing and in PD. In detail, the performance of young and old 
healthy people, and of a group of medicated PD patients was explored in a conflict task, 
in which contingent feedbacks were introduced as motivational incentives. This second 
study had several objectives. First of all, we aimed at exploring the interaction between 
motivation and cognitive control, issue of interest in the recent literature. We wanted to 
add evidences in this field designing a new paradigm, the motivational Simon task, and 
analysing data with a specific method, i.e. the diffusion model analysis. With this 
analysis approach it was possible to evaluate which phase of the response was 
modulated by motivational variables, distinguish between decisional and extra-
decisional components of our participants’ performances. Secondly, we aimed at 
investigating if ageing effects on prefrontal cortex and on the dopaminergic 
functionality could affect the interaction between motivation and cognitive control. 
Following this second aim we applied the motivational Simon task in both, young and 
old healthy subjects. Final objective was to explore how a condition of dopaminergic 
“dysregulation” could affect the interaction between cognitive control and motivation. 
To reach this objective, a new group of medicated PD patients were tested with the 
motivational Simon task; their performance was compared with the group of old healthy 
subjects, matched for age, gender and education. With this last aim, we also referred to 
a clinical application of this exploration, i.e. the applicability of feedback-based 
learning paradigms for the cognitive rehabilitation of medicated PD patients.  
Results of this second study fulfilled our objectives. Exploring the performance of 
healthy subjects with the diffusion model analysis we explored how, and in which 
dimensions, motivation can modulate cognitive control. Our results confirmed that the 
introduction of rewards and punishments in a conflict task is a useful method to explore 
how different motivation states, induced by these two different feedbacks, can lead to 
diverse approaches to the task. Our findings highlighted as a correct processing of 
different motivational incentives, positive or negative, permits to modulate the 
executive components of the response. Healthy people tested in our study were in fact 
able to adjust their performance in relation to different feedbacks and, therefore, 
different motivational states.  
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Young and old healthy subjects, even showing differences in their consideration of 
reward and punishment, were able to modulate their response strategy depending on the 
presence of positive and negative feedbacks, which differently incentivize a successful 
performance.  
However, this capacity is impaired in PD. Analysing the performance of a group of 
medicated PD patients with EF impairment, it was possible to see that in this clinical 
condition the interaction between motivation and cognitive control is impaired. PD 
patients tested in this study did not modulate their performance in response to different 
feedback and, therefore, different motivational states. Unlike healthy subjects matched 
for age, gender and education, our PD patients showed the same performance in both 
the phases of the motivational Simon task, showing the inability to adapt their response 
strategy with the aim to obtain a successful performance. Taken together our results add 
information about how motivational incentives act in the modulation of cognitive 
resource management. Moreover, our results are in line with previous findings, which 
suggested a preserved feedback processing in ageing (Spaniol et al., 2011; Harsay et al., 
2010) and an impaired feedback processing in medicated PD patients (Kapogiannis et 
al., 2011; Kobayakawa et al., 2010; Bodi et al., 2009; Frank et al., 2007-2004).  
On the basis of the results of the second study, the third study presented in this thesis 
was aimed at exploring the electrophysiological correlates of feedback processing in 
medicated PD patients. In detail, we examined the ERPs components related to 
feedback processing in a new sample of medicated PD patients, recording the ERPs 
during the Iowa Gambling Task (IGT; Bechara et al., 1994). Confirming previous 
findings about an impaired performance of PD patients in this task, our results indicated 
that medicated PD patients had a lower performance on the IGT (Gescheidt et al., 2012; 
Kobayakawa et al., 2010; Pagonabarraga et al., 2007; Perretta et al., 2005). Furthermore, 
we also added important information about possible reasons of this lower performance. 
The most important result of this third study is represented by the analysis of feedback 
modulation of the P3 component, i.e. a component sensitive to valence and relevance of 
feedbacks and that reflects context evaluation and performance monitoring (Ferdinand 
& Kray, 2013). In the control condition, which was represented by a group of old 
healthy subjects matched for age, gender and education with the PD patients, we found 
a positivity effect, i.e. a larger P3 amplitudes after positive than after negative feedback. 
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 On the contrary, we did not find any positivity effect in our group of medicated PD 
patients. This result suggested that an impairment in top-down evaluation processes in 
medicated PD patients could be one of the reasons of feedback-processing deficits, 
which can bring to impaired choice evaluation and compromised decision-making 
ability.  
Results of the third study are in line with the results of the second one, and they 
moreover agree with the previously mentioned literature about feedback processing 
abnormalities in medicated PD patients (Kapogiannis et al., 2011; Kobayakawa et al., 
2010; Bodi et al., 2009; Frank et al., 2007-2004). The ERPs analysis of feedback 
processing suggested that in PD patients an incorrect evaluation of context-relevant 
outcome could be the reason of an impaired decision-making, and may be one of the 
reasons for the development of cognitive and behavioural problems related to impulse 
control disorder.  
In conclusion, results of the present dissertation add information about how EF work, in 
the normal and in the pathological condition of PD. In the three works reported, EF 
were studied employing known and new experimental paradigms, with the aim to 
explore some detailed mechanisms never examined before, and to investigate other EF 
components that were previously explored with different, and sometimes inappropriate, 
evaluation methods. Using the terminology of Zelazo & Cunningham (2007), results of 
the present dissertation improve in detail the knowledge about “cool” components of EF, 
i.e. the WM and inhibitory control, and “hot” EF components, i.e. feedback processing 
and decision-making. Furthermore, the three studies reported proposed also an 
investigation of these components in normal ageing and in PD, basing on the 
association between the dopaminergic functionality and these specific EF (Hämmerer & 
Eppinger, 2012; Bäckman et al., 2010-2006; Bäckman & Farde, 2005).  
Exploring these functions in different age classes, we confirm that “cool” components 
of EF, as WM and inhibitory control, are subject to a decline in normal ageing; however, 
we also show that “hot” EF, as feedback processing and decision-making, seem to be 
less affected by ageing. As reported in the first section of this dissertation, the actual 
question about ageing and EF concerns the exploration of which are the age-related 
deficits in executive control (Verhaeghen, 2011). Our results answer this question 
suggesting the presence of differential age-related declines of EF subcomponents, 
according to the hypothesis of West (2000).  
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At the same time, results of the present dissertation also show that medicated PD 
patients are impaired in feedback processing and decision-making, while they show a 
partial impairment in WM and inhibitory control. These results are in line with the 
suggestion of a complex dopaminergic “dysregulation” in medicated PD patients, 
suggesting further exploration of the role of pharmacological treatment in the 
expression of these EF deficits. Moreover, our findings could have important 
implication in clinical practice. Manifesting cognitive and behavioural deficits, PD 
patients can be subjects of cognitive and behavioural rehabilitation programs, which are 
often based on feedback-based learning procedures. To our opinion, a preliminary 
consideration of feedback processing ability in medicated PD patients would be 
appropriate in the rehabilitation setting, to evaluate feasibility and predict efficacy of 
those rehabilitation procedures. If medicated patients manifest a primary impairment in 
the outcome evaluation, every procedure centred on feedback-based learning would be 
inappropriate and ineffective.  
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Generale – 
Mondini S. & Mapelli D. 
 
MINI MENTAL STATE 
EXAMINATION 
-MMSE- 
DATA:………………………….. 
NOME:…………………………………………………………….. 
 
ETA’:……………        SCOLARITA’:………………………….. 	  
ORIENTAMENTO TEMPORALE 
(Iniziare con le 5 domande che riguardano l’orientamento temporale nell’ordine elencato  - 1 punto per ogni risposta 
corretta – max 5p.ti) Mi sa dire in che anno siamo?  
In che stagione?  
In che mese?  
In che giorno del mese siamo?  
E in che giorno della settimana siamo?  
 
ANNO………………………………………………………....[   ] 
 
STAGIONE……………………………………………………[   ]   
MESE…………..……………………………………………...[   ]   
GIORNO DEL MESE……………………….………...……….[   ] 
 
GIORNO DELLA SETTIMANA………….……………...……[   ] 
 
…
/5 
ORIENTAMENTO SPAZIALE 
(Iniziare con le 5 domande che riguardano l’orientamento spaziale nell’ordine elencato  - 1 punto per ogni risposta corretta 
– max 5p.ti) –  
Mi sa dire in che regione siamo?  
In che provincia?  
In che città siamo?  
Sa dirmi come si chiama questo posto, questo edificio?  
A che piano siamo? 
 
REGIONE……….…..…………………………..……………..[   ] 
 
PROVINCIA….….……………………….……………………[   ]   
CITTA’……….…………………………… …...……………...[   ]   
POSTO………..……………………..………...……………….[   ] 
 
PIANO……………….….………………………...……………[   ] 
 
…
/5 
REGISTRAZIONE 
(Leggere le 3 parole e chiedere immediatamente le parole lette - 1 p.to a parola ripetuta correttamente e nell’ordine 
corretto – max 3p.ti) – Adesso ascolti e ripeta le parole che le leggerò, esattamente nello 
stesso ordine 
CASA – PANE – GATTO 
[   ]    -   [   ]   -     [   ] 
 
…………………………………………………	   …/3 
CALCOLO 
(Iniziare con la prova di sottrazione a partire dalla cifra 100 e togliere poi  il numero 7. Possibile dare UN SOLO 
suggerimento 1 p.to per risposta corretta o 1.pto per sottrazione corretta rispetto all’ultima cifra detta – max 5.p.ti) –  
Adesso faremo qualche calcolo. Deve partire dal numero 100 e sottrarre 7. Dal 
risultato toglie ancora 7 e così via fino a quando non la fermo. Incominciamo, 100-7? 
 
93   -   86   -   79   -   72   -   65 
[   ]  -  [   ]   -  [   ]   -  [   ]   -  [   ] 
 
____  -   ____   -   ____   -   ____   -   ____ 
[   ]  -     [   ]    -    [   ]    -    [   ]    -     [   ] 	  
 
SPELLING ALL’INDIETRO  
(Eseguire solo nel caso in cui il paziente non riporti il punteggio pieno di 5/5 alla prova di calcolo. 
Contare quante parole sono sillabate correttamente e nella corretta succesione inversa della parola CARNE 1p.to per ogni 
lettera corretta nella corretta posizione – max 5p.ti) –  
La parola CARNE è formata da 5 lettere. Le chiedo di dirmi queste lettere, 
dall’ultima, ad una ad una fino alla prima 
E     -    N    -    R     -    A    -    C 
[   ]  -  [   ]   -  [   ]   -  [   ]   -  [   ]	   …/5 
RIEVOCAZIONE 
(Far rievocare 3 parole 1p.to a parola ripetuta correttamente l’ordine non conta – max 3p.ti) –  
Ricorda le 3 parole che le ho letto poco fa e che lei ha ripetuto? 
CASA – PANE – GATTO 
                                    [   ]    -   [   ]   -     [   ] 
 
………………………………………………… 
…
/3 
DENOMINAZIONE 
(Mostrare una matita e un orologio, non allacciato al polso. Chiedere al paziente di dire il nome dei due oggetti presentati 
uno dopo l’altro 1p.to per ogni oggetto correttamente riconosciuto – max 2p.ti) – 
Sa dirmi il nome di questo oggetto? E il nome di questo? 
MATITA 
[   ] 
 
OROLOGIO 
[   ] 
 
………………………………………………………….. 
…
/2 
RIPETIZIONE DI FRASE 
(Chiedere al paziente di ripetere la frase letta max 1p.to) -   
Adesso le leggerò una frase, uno sciogli-lingua. Mi ascolti attentamente e lo ripeta 
senza errori. 
 
TIGRE CONTRO TIGRE 
 
………………………………………………………. 
…
/1 
ORDINE ORALE 
(Si richiede al paziente di eseguire una serie di istruzioni comunicate. Non è possibile dare suggerimenti o ripetere l’ordine - 
1p.to per ogni istruzione compiuta correttamente – max 3p.ti) –  
Prenda questo foglio con la mano destra/sinistra (mano dominante), lo pieghi a metà e 
poi me lo restituisca. 
MANO DESTRA/sinistra   -   PIEGARE   -   RESTITUIRE 
[   ]      -        [   ]     -     [   ]	   …/3 
ORDINE SCRITTO 
(Se permangono errori di lettura passare alla prova successiva e attribuire p.teggio pari a 0. Se è necessario chiedere espressamente di chiudere gli occhi attribuire p.teggio pari a 0 max 1p.to per esecuzione come da istruzioni ) –  
Presentare al paziente il foglio con scritto “CHIUDI GLI OCCHI”e chiedere di leggerlo. Fare in modo che il paziente legga il correttamente. Successivamente chiedere 
al paziente:”E’ un ordine, deve fare quello che è scritto”.  
…
/1 
SCRITTURA 
(Chiedere al paziente di scrivere una frase. La frase dovrebbe avere almeno un soggetto ed un verbo max 1p.to) –  
Vede questo foglio? Le chiedo di scrivere qui una frase, un pensiero che ha in mente. 
…
/1 
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PRASSIA COSTRUTTIVA 
(Mostrare al paziente i due pentagoni incrociati e chiedere di ricopiarli uguali nello spazio adiacente max 1p.to) –  
Vede questa figura. Le chiedo di copiarla uguale. 
…
/1 
PUNTEGGIO GREZZO:  …./30                |             PUNTEGGIO CORR. :   …./30 
	  
	  	  	  	  	  	  	  	  
 
 
 
